false2023FY0001567925truehttp://fasb.org/us-gaap/2023#AssetImpairmentChargeshttp://fasb.org/us-gaap/2023#AssetImpairmentChargeshttp://fasb.org/us-gaap/2023#AssetImpairmentChargeshttp://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrenthttp://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent00015679252023-01-012023-12-310001567925us-gaap:CommonClassAMember2023-06-30iso4217:USD0001567925cik0001567925:CommonClassIMember2023-06-300001567925cik0001567925:CommonClassTMember2023-06-300001567925cik0001567925:CommonClassT2Member2023-06-300001567925us-gaap:CommonClassAMember2024-02-29xbrli:shares0001567925cik0001567925:CommonClassIMember2024-02-290001567925cik0001567925:CommonClassTMember2024-02-290001567925cik0001567925:CommonClassT2Member2024-02-2900015679252023-10-012023-12-3100015679252023-12-3100015679252022-12-31iso4217:USDxbrli:shares00015679252022-01-012022-12-3100015679252021-01-012021-12-310001567925us-gaap:CommonStockMember2022-12-310001567925us-gaap:AdditionalPaidInCapitalMember2022-12-310001567925us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2022-12-310001567925us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001567925us-gaap:CommonStockMember2023-01-012023-12-310001567925us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-310001567925us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2023-01-012023-12-310001567925us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-310001567925us-gaap:CommonStockMember2023-12-310001567925us-gaap:AdditionalPaidInCapitalMember2023-12-310001567925us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2023-12-310001567925us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001567925us-gaap:CommonStockMember2021-12-310001567925us-gaap:AdditionalPaidInCapitalMember2021-12-310001567925us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2021-12-310001567925us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-3100015679252021-12-310001567925us-gaap:CommonStockMember2022-01-012022-12-310001567925us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001567925us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2022-01-012022-12-310001567925us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001567925us-gaap:CommonStockMember2020-12-310001567925us-gaap:AdditionalPaidInCapitalMember2020-12-310001567925us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2020-12-310001567925us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-3100015679252020-12-310001567925us-gaap:CommonStockMember2021-01-012021-12-310001567925us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001567925us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2021-01-012021-12-310001567925us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001567925cik0001567925:OperatingPartnershipMember2023-01-012023-12-31xbrli:pure0001567925srt:MinimumMemberus-gaap:BuildingAndBuildingImprovementsMember2023-12-310001567925srt:MaximumMemberus-gaap:BuildingAndBuildingImprovementsMember2023-12-310001567925srt:MinimumMemberus-gaap:FurnitureAndFixturesMember2023-12-310001567925srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2023-12-31cik0001567925:segmentcik0001567925:propertycik0001567925:acquistion0001567925cik0001567925:WestPalmBeachHealthcareFacilityMember2023-06-150001567925cik0001567925:WestPalmBeachHealthcareFacilityMember2023-06-152023-06-150001567925cik0001567925:BurrRidgeHealthcareFacilityMember2023-09-270001567925cik0001567925:BurrRidgeHealthcareFacilityMember2023-09-272023-09-270001567925us-gaap:LandMember2023-01-012023-12-310001567925us-gaap:BuildingAndBuildingImprovementsMember2023-01-012023-12-310001567925cik0001567925:TenantImprovementsMember2023-01-012023-12-310001567925us-gaap:LeasesAcquiredInPlaceMember2023-01-012023-12-310001567925us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercik0001567925:A2023RealEstatePropertyDisposition1Member2023-12-310001567925us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembercik0001567925:HoustonTheWoodlandsSugarLandTexasMSAMember2023-12-31cik0001567925:statisticalArea0001567925us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembercik0001567925:HoustonTheWoodlandsSugarLandTexasMSAMember2023-01-012023-12-310001567925us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembercik0001567925:OneTenantMember2023-12-31cik0001567925:tenant0001567925us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembercik0001567925:PostAcuteMedicalLLCAndAffiliatesMember2023-01-012023-12-310001567925us-gaap:AboveMarketLeasesMember2023-01-012023-12-310001567925us-gaap:LeasesAcquiredInPlaceMember2022-01-012022-12-310001567925us-gaap:DiscontinuedOperationsHeldforsaleMembercik0001567925:DataCentersMember2021-05-190001567925us-gaap:DiscontinuedOperationsDisposedOfBySaleMembercik0001567925:DataCentersMember2021-07-220001567925us-gaap:DiscontinuedOperationsDisposedOfBySaleMembercik0001567925:DataCentersMember2021-07-222021-07-2200015679252021-07-2200015679252021-07-302021-07-300001567925us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMembercik0001567925:DataCentersMember2021-01-012021-12-310001567925us-gaap:DiscontinuedOperationsDisposedOfBySaleMembercik0001567925:DataCentersMember2021-01-012021-12-310001567925us-gaap:LeasesAcquiredInPlaceMember2023-12-310001567925us-gaap:LeasesAcquiredInPlaceMember2022-12-310001567925us-gaap:AboveMarketLeasesMember2023-12-310001567925us-gaap:AboveMarketLeasesMember2022-12-310001567925us-gaap:AboveMarketLeasesMember2022-01-012022-12-310001567925us-gaap:CostOfSalesMember2023-01-012023-12-310001567925us-gaap:CostOfSalesMember2022-01-012022-12-310001567925us-gaap:CostOfSalesMember2021-01-012021-12-310001567925cik0001567925:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToParentMember2023-01-012023-12-310001567925cik0001567925:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToParentMember2022-01-012022-12-310001567925cik0001567925:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToParentMember2021-01-012021-12-310001567925us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-12-310001567925us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-12-310001567925us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-12-310001567925us-gaap:RevolvingCreditFacilityMember2023-01-012023-12-310001567925us-gaap:RevolvingCreditFacilityMember2022-01-012022-12-310001567925us-gaap:RevolvingCreditFacilityMember2021-01-012021-12-310001567925us-gaap:RevolvingCreditFacilityMembercik0001567925:VariableRateLineOfCreditMember2023-12-310001567925us-gaap:RevolvingCreditFacilityMembercik0001567925:VariableRateLineOfCreditMember2022-12-310001567925us-gaap:UnsecuredDebtMembercik0001567925:VariableRateTermLoanSubjectToInterestRateSwapMember2023-12-310001567925us-gaap:UnsecuredDebtMembercik0001567925:VariableRateTermLoanSubjectToInterestRateSwapMember2022-12-310001567925us-gaap:UnsecuredDebtMembercik0001567925:VariableRateTermLoanMember2023-12-310001567925us-gaap:UnsecuredDebtMembercik0001567925:VariableRateTermLoanMember2022-12-310001567925cik0001567925:InterestRateSwapEffectiveDateMarch12023Member2023-02-170001567925us-gaap:RevolvingCreditFacilityMember2023-03-082023-03-080001567925us-gaap:UnsecuredDebtMember2023-04-132023-04-130001567925us-gaap:UnsecuredDebtMember2023-07-132023-07-130001567925us-gaap:RevolvingCreditFacilityMember2023-09-262023-09-260001567925us-gaap:RevolvingCreditFacilityMember2023-11-012023-11-010001567925us-gaap:RevolvingCreditFacilityMember2023-12-192023-12-190001567925us-gaap:UnsecuredDebtMember2023-12-192023-12-19cik0001567925:Extension0001567925us-gaap:RevolvingCreditFacilityMember2023-12-310001567925cik0001567925:A2024TermLoanMemberus-gaap:UnsecuredDebtMember2023-12-310001567925cik0001567925:A2028TermLoanMemberus-gaap:UnsecuredDebtMember2023-12-310001567925srt:MinimumMemberus-gaap:BaseRateMembercik0001567925:A2028TermLoanMemberus-gaap:UnsecuredDebtMember2023-01-012023-12-310001567925srt:MaximumMemberus-gaap:BaseRateMembercik0001567925:A2028TermLoanMemberus-gaap:UnsecuredDebtMember2023-01-012023-12-310001567925srt:MinimumMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembercik0001567925:A2028TermLoanMemberus-gaap:UnsecuredDebtMember2023-01-012023-12-310001567925srt:MaximumMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembercik0001567925:A2028TermLoanMemberus-gaap:UnsecuredDebtMember2023-01-012023-12-310001567925cik0001567925:A2028TermLoanMemberus-gaap:UnsecuredDebtMember2023-01-012023-12-310001567925us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001567925us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001567925us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-12-310001567925us-gaap:FairValueMeasurementsRecurringMember2023-12-310001567925us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001567925us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001567925us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001567925us-gaap:FairValueMeasurementsRecurringMember2022-12-310001567925us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsNonrecurringMember2023-12-310001567925us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-310001567925us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Member2023-12-310001567925us-gaap:FairValueMeasurementsNonrecurringMember2023-12-310001567925us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001567925us-gaap:FairValueMeasurementsNonrecurringMember2023-01-012023-12-310001567925us-gaap:MeasurementInputCapRateMemberus-gaap:FairValueInputsLevel3Member2023-12-310001567925us-gaap:MeasurementInputDiscountRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Member2023-12-310001567925srt:MinimumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputCostToSellMember2023-12-31iso4217:USDcik0001567925:sqft0001567925srt:MaximumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputCostToSellMember2023-12-310001567925us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001567925us-gaap:InterestRateSwapMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001567925us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableMember2023-12-310001567925us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001567925us-gaap:InterestRateSwapMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001567925us-gaap:InterestRateSwapMember2023-01-012023-12-310001567925us-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2023-01-012023-12-310001567925us-gaap:InterestRateSwapMember2022-01-012022-12-310001567925us-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2022-01-012022-12-310001567925us-gaap:SegmentContinuingOperationsMemberus-gaap:InterestRateSwapMember2021-01-012021-12-310001567925us-gaap:SegmentContinuingOperationsMemberus-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2021-01-012021-12-310001567925us-gaap:SegmentContinuingOperationsMember2021-01-012021-12-310001567925us-gaap:InterestRateSwapMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMembercik0001567925:DataCentersMember2021-01-012021-12-310001567925cik0001567925:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToParentMemberus-gaap:InterestRateSwapMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMembercik0001567925:DataCentersMember2021-01-012021-12-310001567925us-gaap:SubsequentEventMember2024-01-082024-01-080001567925us-gaap:CommonStockMembercik0001567925:ClassAIAndTSharesMember2023-01-012023-12-310001567925us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-01-012023-12-310001567925cik0001567925:CommonClassIMemberus-gaap:CommonStockMember2023-01-012023-12-310001567925us-gaap:CommonStockMembercik0001567925:CommonClassTMember2023-01-012023-12-310001567925us-gaap:CommonStockMembercik0001567925:ClassAIAndTSharesMember2022-01-012022-12-310001567925us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-01-012022-12-310001567925cik0001567925:CommonClassIMemberus-gaap:CommonStockMember2022-01-012022-12-310001567925us-gaap:CommonStockMembercik0001567925:CommonClassTMember2022-01-012022-12-310001567925us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-12-310001567925us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-12-310001567925us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310001567925us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-12-310001567925us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001567925us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-12-310001567925us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310001567925us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-12-310001567925us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-12-310001567925us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-12-310001567925us-gaap:CommonClassAMember2020-03-060001567925cik0001567925:RestrictedClassACommonStockAndPerformanceDSUsMember2023-12-310001567925cik0001567925:RestrictedClassACommonStockAndPerformanceDSUsMember2022-12-310001567925cik0001567925:RestrictedClassACommonStockAndPerformanceDSUsMember2023-01-012023-12-310001567925cik0001567925:RestrictedClassACommonStockAndPerformanceDSUsMember2023-01-012023-12-310001567925cik0001567925:CommonClassAITandT2SharesMember2023-01-012023-12-310001567925cik0001567925:CommonClassAITandT2SharesMember2022-01-012022-12-310001567925cik0001567925:CommonClassAITandT2SharesMember2021-01-012021-12-310001567925cik0001567925:SpecialDistributionsMember2023-01-012023-12-310001567925cik0001567925:SpecialDistributionsMember2022-01-012022-12-310001567925cik0001567925:SpecialDistributionsMember2021-01-012021-12-310001567925us-gaap:CommonClassAMemberus-gaap:SubsequentEventMember2024-01-082024-01-080001567925cik0001567925:CommonClassIMemberus-gaap:SubsequentEventMember2024-01-082024-01-080001567925us-gaap:SubsequentEventMembercik0001567925:CommonClassTMember2024-01-082024-01-080001567925us-gaap:CommonClassAMemberus-gaap:SubsequentEventMember2024-02-072024-02-070001567925cik0001567925:CommonClassIMemberus-gaap:SubsequentEventMember2024-02-072024-02-070001567925us-gaap:SubsequentEventMembercik0001567925:CommonClassTMember2024-02-072024-02-070001567925us-gaap:SubsequentEventMember2024-02-072024-02-070001567925us-gaap:CommonClassAMemberus-gaap:SubsequentEventMember2024-01-152024-01-150001567925cik0001567925:CommonClassIMemberus-gaap:SubsequentEventMember2024-01-152024-01-150001567925us-gaap:SubsequentEventMembercik0001567925:CommonClassTMember2024-01-152024-01-150001567925us-gaap:CommonClassAMemberus-gaap:SubsequentEventMember2024-02-152024-02-150001567925cik0001567925:CommonClassIMemberus-gaap:SubsequentEventMember2024-02-152024-02-150001567925us-gaap:SubsequentEventMembercik0001567925:CommonClassTMember2024-02-152024-02-150001567925us-gaap:CommonClassAMemberus-gaap:SubsequentEventMember2024-03-052024-03-050001567925cik0001567925:CommonClassIMemberus-gaap:SubsequentEventMember2024-03-052024-03-050001567925us-gaap:SubsequentEventMembercik0001567925:CommonClassTMember2024-03-052024-03-050001567925us-gaap:SubsequentEventMembercik0001567925:CommonClassAIAndTSharesMember2024-02-012024-02-290001567925us-gaap:SubsequentEventMembercik0001567925:CommonClassAIAndTSharesMembersrt:ScenarioForecastMember2024-03-012024-03-310001567925cik0001567925:CommonClassAIAndTSharesMembersrt:ScenarioForecastMember2024-04-012024-04-300001567925us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberus-gaap:SubsequentEventMembercik0001567925:NewBedfordHealthcareFacilityMember2024-01-310001567925us-gaap:SubsequentEventMember2024-01-312024-01-310001567925us-gaap:SubsequentEventMembercik0001567925:BrownsburgHealthcareFacilityMember2024-02-260001567925us-gaap:SubsequentEventMembercik0001567925:BrownsburgHealthcareFacilityMember2024-02-262024-02-260001567925cik0001567925:HoustonHealthcareFacilityf.k.a.CyFairSurgicalCenterMember2023-12-310001567925cik0001567925:CincinnatiHealthcareFacilityf.k.a.MercyHealthcareFacilityMember2023-12-310001567925cik0001567925:WinstonSalemHealthcareFacilityf.k.a.WinstonSalemNCIMFMember2023-12-310001567925cik0001567925:StoughtonHealthcareFacilityf.k.a.NewEnglandSinaiMedicalCenterMember2023-12-310001567925cik0001567925:FortWorthHealthcareFacilityf.k.a.BaylorSurgicalHospitalatFortWorthMember2023-12-310001567925cik0001567925:FortWorthHealthcareFacilityIIf.k.a.BaylorSurgicalHospitalIntegratedMedicalFacilityMember2023-12-310001567925cik0001567925:WinterHavenHealthcareFacilityMember2023-12-310001567925cik0001567925:OverlandParkHealthcareFacilityf.k.a.HeartlandRehabilitationHospitalMember2023-12-310001567925cik0001567925:ClarionHealthcareFacilityf.k.a.ClarionIMFMember2023-12-310001567925cik0001567925:WebsterHealthcareFacilityf.k.a.PostAcuteWebsterRehabilitationHospitalMember2023-12-310001567925cik0001567925:AugustaHealthcareFacilityf.k.a.KMOIMFAugustaMember2023-12-310001567925cik0001567925:CincinnatiHealthcareFacilityIIIf.k.a.KMOIMFCincinnatiIIMember2023-12-310001567925cik0001567925:FlorenceHealthcareFacilityf.k.a.KMOIMFFlorenceMember2023-12-310001567925cik0001567925:OaklandHealthcareFacilityf.k.a.KMOIMFOaklandMember2023-12-310001567925cik0001567925:WyomissingHealthcareFacilityf.k.a.ReadingSurgicalHospitalMember2023-12-310001567925cik0001567925:LulingHealthcareFacilityf.k.a.PostAcuteWarmSpringsSpecialtyHospitalofLulingMember2023-12-310001567925cik0001567925:OmahaHealthcareFacilityf.k.a.NebraskaHealthcareFacilityMember2023-12-310001567925cik0001567925:ShermanHealthcareFacilityf.k.a.HeritageParkShermanIMember2023-12-310001567925cik0001567925:ShermanHealthcareFacilityIIf.k.a.HeritageParkShermanIIMember2023-12-310001567925cik0001567925:FortWorthHealthcareFacilityIIIf.k.a.BaylorSurgeryCenteratFortWorthMember2023-12-310001567925cik0001567925:OklahomaCityHealthcareFacilityf.k.a.HPIOklahomaCityIMember2023-12-310001567925cik0001567925:OklahomaCityHealthcareFacilityIIf.k.a.HPIOklahomaCityIIMember2023-12-310001567925cik0001567925:EdmondHealthcareFacilityf.k.a.HPIEdmondMember2023-12-310001567925cik0001567925:OklahomaCityHealthcareFacilityIIIf.k.a.HPIOklahomaCityIVMember2023-12-310001567925cik0001567925:OklahomaCityHealthcareFacilityIVf.k.a.HPIOklahomaCityIIIMember2023-12-310001567925cik0001567925:NewcastleHealthcareFacilityf.k.a.HPINewcastleMember2023-12-310001567925cik0001567925:OklahomaCityHealthcareFacilityVf.k.a.HPIOklahomaCityVMember2023-12-310001567925cik0001567925:RanchoMirageHealthcareFacilityf.k.a.VibraRehabilitationHospitalMember2023-12-310001567925cik0001567925:OklahomaCityHealthcareFacilityVIf.k.a.HPIOklahomaCityVIMember2023-12-310001567925cik0001567925:OklahomaCityHealthcareFacilityVIIf.k.a.HPIOklahomaCityVIIMember2023-12-310001567925cik0001567925:LasVegasHealthcareFacilityf.k.a.PostAcuteLasVegasRehabilitationHospitalMember2023-12-310001567925cik0001567925:OklahomaCityHealthcareFacilityVIIIf.k.a.IntegrisLakesideWomensHospitalMember2023-12-310001567925cik0001567925:MarltonHealthcareFacilityf.k.a.SelectMedicalRehabilitationFacilityMember2023-12-310001567925cik0001567925:GrandRapidsHealthcareFacilityMember2023-12-310001567925cik0001567925:CorpusChristiHealthcareFacilityf.k.a.CorpusChristiSurgeryCenterMember2023-12-310001567925cik0001567925:AuroraHealthcareFacilityMember2023-12-310001567925cik0001567925:AllenHealthcareFacilityf.k.a.TexasRehabAllenMember2023-12-310001567925cik0001567925:AustinHealthcareFacilityf.k.a.TexasRehabAustinMember2023-12-310001567925cik0001567925:BeaumontHealthcareFacilityf.k.a.TexasRehabBeaumontMember2023-12-310001567925cik0001567925:SanAntonioHealthcareFacilityf.k.a.TexasRehabSanAntonioMember2023-12-310001567925cik0001567925:SilverdaleHealthcareFacilityMember2023-12-310001567925cik0001567925:SilverdaleHealthcareFacilityTwoMember2023-12-310001567925cik0001567925:SaginawHealthcareFacilityMember2023-12-310001567925cik0001567925:CarrolltonHealthcareFacilityMember2023-12-310001567925cik0001567925:KatyHealthcareFacilityf.k.a.OceansKatyBehavioralHealthHospitalMember2023-12-310001567925cik0001567925:IndianolaHealthcareFacilityf.k.a.IndianolaHealthcareIMember2023-12-310001567925cik0001567925:IndianolaHealthcareFacilityIIf.k.a.IndianolaHealthcareIIMember2023-12-310001567925cik0001567925:BentonHealthcareFacilityf.k.a.BentonHealthcareIBentonMember2023-12-310001567925cik0001567925:BentonHealthcareFacilityIIf.k.a.BentonHealthcareIIIBentonMember2023-12-310001567925cik0001567925:BryantHealthcareFacilityf.k.a.BentonHealthcareIIBryantMember2023-12-310001567925cik0001567925:HotSpringsHealthcareFacilityf.k.a.BentonHealthcareIVHotSpringsHotSpringsMember2023-12-310001567925cik0001567925:CliveHealthcareFacilityMember2023-12-310001567925cik0001567925:ValdostaHealthcareFacilityf.k.a.ValdostaHealthcareIMember2023-12-310001567925cik0001567925:ValdostaHealthcareFacilityIIf.k.a.ValdostaHealthcareIIMember2023-12-310001567925cik0001567925:BryantHealthcareFacilityIIf.k.a.BryantHealthcareFacilityMember2023-12-310001567925cik0001567925:LaredoHealthcareFacilityMember2023-12-310001567925cik0001567925:LaredoHealthcareFacilityTwoMember2023-12-310001567925cik0001567925:PoplarBluffHealthcareFacilityMember2023-12-310001567925cik0001567925:TucsonHealthcareFacilityMember2023-12-310001567925cik0001567925:AkronHealthcareFacilityMember2023-12-310001567925cik0001567925:AkronHealthcareFacilityTwoMember2023-12-310001567925cik0001567925:AkronHealthcareFacilityThreeMember2023-12-310001567925cik0001567925:AlexandriaHealthcareFacilityMember2023-12-310001567925cik0001567925:AppletonHealthcareFacilityMember2023-12-310001567925cik0001567925:AustinHealthcareFacilityTwoMember2023-12-310001567925cik0001567925:BellevueHealthcareFacilityMember2023-12-310001567925cik0001567925:BonitaSpringsHealthcareFacilityMember2023-12-310001567925cik0001567925:BridgetonHealthcareFacilityMember2023-12-310001567925cik0001567925:CovingtonHealthcareFacilityMember2023-12-310001567925cik0001567925:CrestviewHealthcareFacilityMember2023-12-310001567925cik0001567925:DallasHealthcareFacilityMember2023-12-310001567925cik0001567925:DePereHealthcareFacilityMember2023-12-310001567925cik0001567925:DenverHealthcareFacilityMember2023-12-310001567925cik0001567925:ElSegundoHealthcareFacilityMember2023-12-310001567925cik0001567925:FairleaHealthcareFacilityMember2023-12-310001567925cik0001567925:FayettevilleHealthcareFacilityMember2023-12-310001567925cik0001567925:FortMyersHealthcareFacilityMember2023-12-310001567925cik0001567925:FortMyersHealthcareFacilityTwoMember2023-12-310001567925cik0001567925:FortWaltonBeachHealthcareFacilityMember2023-12-310001567925cik0001567925:FrankfortHealthcareFacilityMember2023-12-310001567925cik0001567925:FriscoHealthcareFacilityMember2023-12-310001567925cik0001567925:GoshenHealthcareFacilityMember2023-12-310001567925cik0001567925:HammondHealthcareFacilityMember2023-12-310001567925cik0001567925:HammondHealthcareFacilityTwoMember2023-12-310001567925cik0001567925:HendersonHealthcareFacilityMember2023-12-310001567925cik0001567925:HoustonHealthcareFacilityThreeMember2023-12-310001567925cik0001567925:HowardHealthcareFacilityMember2023-12-310001567925cik0001567925:JacksonvilleHealthcareFacilityMember2023-12-310001567925cik0001567925:LafayetteHealthcareFacilityMember2023-12-310001567925cik0001567925:LakewoodRanchHealthcareFacilityMember2023-12-310001567925cik0001567925:LasVegasHealthcareFacilityIIMember2023-12-310001567925cik0001567925:LehighAcresHealthcareFacilityMember2023-12-310001567925cik0001567925:LubbockHealthcareFacilityMember2023-12-310001567925cik0001567925:ManitowocHealthcareFacilityMember2023-12-310001567925cik0001567925:ManitowocHealthcareFacilityTwoMember2023-12-310001567925cik0001567925:MarinetteHealthcareFacilityMember2023-12-310001567925cik0001567925:NewBedfordHealthcareFacilityMember2023-12-310001567925cik0001567925:NewBraunfelsHealthcareFacilityMember2023-12-310001567925cik0001567925:NorthSmithfieldHealthcareFacilityMember2023-12-310001567925cik0001567925:OklahomaHealthcareFacilityIXMember2023-12-310001567925cik0001567925:OshkoshHealthcareFacilityMember2023-12-310001567925cik0001567925:PalmDesertHealthcareFacilityMember2023-12-310001567925cik0001567925:RanchoMirageHealthcareFacilityTwoMember2023-12-310001567925cik0001567925:SanAntonioHealthcareFacilityThreeMember2023-12-310001567925cik0001567925:SanAntonioHealthcareFacilityFourMember2023-12-310001567925cik0001567925:SanAntonioHealthcareFacilityFiveMember2023-12-310001567925cik0001567925:SantaRosaBeachHealthcareFacilityMember2023-12-310001567925cik0001567925:SavannahHealthcareFacilityMember2023-12-310001567925cik0001567925:SturgeonBayHealthcareFacilityMember2023-12-310001567925cik0001567925:VictoriaHealthcareFacilityMember2023-12-310001567925cik0001567925:VictoriaHealthcareFacilityIIMember2023-12-310001567925cik0001567925:WilkesBarreHealthcareFacilityIMember2023-12-310001567925cik0001567925:YuccaValleyHealthcareFacilityMember2023-12-310001567925cik0001567925:TucsonHealthcareFacilityTwoMember2023-12-310001567925cik0001567925:TucsonHealthcareFacilityThreeMember2023-12-310001567925cik0001567925:GrimesHealthcareFacilityMember2023-12-310001567925cik0001567925:TampaHealthcareFacilityMember2023-12-310001567925cik0001567925:TucsonHealthcareFacilityFourMember2023-12-310001567925cik0001567925:GreenwoodHealthcareFacilityMember2023-12-310001567925cik0001567925:CliveHealthcareFacilityTwoMember2023-12-310001567925cik0001567925:CliveHealthcareFacilityThreeMember2023-12-310001567925cik0001567925:CliveHealthcareFacilityFourMember2023-12-310001567925cik0001567925:CliveUndevelopedLandMember2023-12-310001567925cik0001567925:CliveUndevelopedLandTwoMember2023-12-310001567925cik0001567925:YukonHealthcareFacilityMember2023-12-310001567925cik0001567925:PleasantHillsHealthcareFacilityMember2023-12-310001567925cik0001567925:ProsserHealthcareFacilityIMember2023-12-310001567925cik0001567925:ProsserHealthcareFacilityIIMember2023-12-310001567925cik0001567925:ProsserHealthcareFacilityIIIMember2023-12-310001567925cik0001567925:TampaHealthcareFacilityIIMember2023-12-310001567925cik0001567925:EscondidoHealthcareFacilityMember2023-12-310001567925cik0001567925:WestPalmBeachHealthcareFacilityMember2023-12-310001567925cik0001567925:BurrRidgeHealthcareFacilityMember2023-12-310001567925srt:MinimumMember2023-12-310001567925srt:MaximumMember2023-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________________
FORM 10-K
(Mark One)
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2023
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File Number: 000-55435
SRT Logo_Full Color.jpg
SILA REALTY TRUST, INC.
(Exact name of registrant as specified in its charter)
Maryland46-1854011
(State or Other Jurisdiction of Incorporation or Organization)(I.R.S. Employer Identification No.)
1001 Water Street, Suite 800
Tampa, FL 33602
(813) 287-0101
(Address of Principal Executive Offices; Zip Code)(Registrant’s Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act: None
Title of each classTrading SymbolName of each exchange on which registered
N/AN/AN/A
Securities registered pursuant to Section 12(g) of the Act:
Common stock, par value $0.01 per share
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes  ☐   No ☒
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes  ☐    No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer 
  Accelerated filer 
Non-accelerated filer 
  Smaller reporting company 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes      No  ☒
There is no established market for the Registrant’s shares of common stock.
As of June 30, 2023, the last business day of the Registrant's most recently completed second fiscal quarter, there were approximately 168,697,000 shares of Class A common stock, 16,865,000 shares of Class I common stock, 41,405,000 shares of Class T common stock and 0 shares of Class T2 common stock held by non-affiliates, for an aggregate market value of approximately $1,371,507,000, $137,112,000, $336,623,000 and $0, respectively, assuming a market value of $8.13 per share of our Class A common stock, Class I common stock, Class T common stock and Class T2 common stock, based on the Registrant's estimated per share net asset value as of June 30, 2023, of the Registrant's common stock established by the Registrant's board of directors at that time.
As of February 29, 2024, there were approximately 169,361,000 shares of Class A common stock, 17,019,000 shares of Class I common stock, 41,891,000 shares of Class T common stock and 0 shares of Class T2 common stock of Sila Realty Trust, Inc. outstanding.
Documents Incorporated by Reference
Portions of Registrant’s proxy statement for the 2024 annual stockholders meeting, to be filed with the Securities and Exchange Commission within 120 days after the end of the Registrant’s fiscal year ended December 31, 2023, are incorporated by reference in Part III. Items 10, 11, 12, 13 and 14.



SILA REALTY TRUST, INC.
(A Maryland Corporation)
TABLE OF CONTENTS
  Page
Item 1.
Item 1A.
Item 1B.
Item 1C.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.
Item 7.
Item 7A.
Item 8.
Item 9.
Item 9A.
Item 9B.
Item 9C.
Item 10.
Item 11.
Item 12.
Item 13.
Item 14.
Item 15.
Item 16.





CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Certain statements contained in this Annual Report on Form 10-K of Sila Realty Trust, Inc., other than historical facts, may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. We intend for all such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Securities Act and the Exchange Act, as applicable by law. Such statements include, in particular, statements about our plans, strategies, goals, objectives, initiatives, financial position, prospects, competition, future transactions, acquisitions and partnerships, availability of funds, payment of distributions, share repurchases, capital and other significant expenditures, and liquidity, and are subject to certain risks and uncertainties, as well as known and unknown risks, which could cause actual results to differ materially from those projected or anticipated. Therefore, such statements are not intended to be a guarantee of our performance in future periods. Such forward-looking statements can generally be identified by our use of forward-looking terminology such as “may,” “will,” “would,” “could,” “should,” “expect,” “intend,” “anticipate,” “estimate,” “believe,” “continue,” or other similar words. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date this Annual Report on Form 10-K is filed with the U.S. Securities and Exchange Commission, or SEC. We make no representation or warranty (express or implied) about the accuracy of any such forward-looking statements contained in this Annual Report on Form 10-K, and we do not undertake to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Forward-looking statements that were true at the time made may ultimately prove to be incorrect or false. We caution investors not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date of this Annual Report on Form 10-K. We undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results. The forward-looking statements should be read in light of the risk factors identified in the Item 1A. Risk Factors section of this Annual Report on Form 10-K.


1

Table of Contents
PART I.
Item 1. Business.
General Description of Business and Operations
Sila Realty Trust, Inc. is a Maryland corporation that was formed on January 11, 2013, headquartered in Tampa, Florida, that has elected, and currently qualifies, to be taxed as a real estate investment trust, or a REIT, under the Internal Revenue Code of 1986, as amended, or the Code, for federal income tax purposes. Substantially all of Sila Realty Trust, Inc.'s business is conducted through Sila Realty Operating Partnership, LP, a Delaware limited partnership, or the Operating Partnership. Sila Realty Trust, Inc. is the sole general partner of the Operating Partnership and directly and indirectly owns 100% of the Operating Partnership. Except as the context otherwise requires, “we,” “our,” “us,” and the “Company” refer to Sila Realty Trust, Inc., our Operating Partnership and all wholly-owned subsidiaries.
We are an internally managed company primarily focused on investing in high quality healthcare assets across the continuum of care, which we believe typically generate predictable, durable and growing income streams. We may also make other real estate-related investments, which may include equity or debt interests in other real estate entities.
We formerly invested in data center properties. During the second quarter of 2021, our board of directors, or the Board, made a determination to sell our data center properties. On May 19, 2021, we and certain of our wholly-owned subsidiaries entered into a purchase and sale agreement, or the PSA, for the sale of up to 29 data center properties owned by us, which constituted the entirety of our data center segment, or the Data Center Sale. On July 22, 2021, we completed the sale of all 29 of the data center properties for an aggregate sale price of $1,320,000,000, and generated net proceeds of approximately $1,295,367,000. Concurrently, the Board declared a special cash distribution of $1.75 per share of Class A, Class I, Class T and Class T2 shares of common stock. The special cash distribution was funded with the proceeds from the sale of the data center properties. The special cash distribution was paid on July 30, 2021 to stockholders of record at the close of business on July 26, 2021, in the aggregate amount of approximately $392,685,000. The decision of the Board to sell the data center properties, as well as the execution of the PSA, represented a strategic shift that had a major effect on our results and operations for the periods presented. The operations of the data center segment have been classified as income from discontinued operations on the consolidated statements of comprehensive income for the year ended December 31, 2021.
We raised the equity capital for our real estate investments through two public offerings, or our Offerings, from May 2014 through November 2018, and we have offered shares through our distribution reinvestment plan, or the DRIP, pursuant to three Registration Statements on Form S-3, together the DRIP Offerings and each a DRIP Offering, since November 2017.
As of December 31, 2023, we owned 131 real estate healthcare properties and two undeveloped land parcels.
We have historically established, and intend to continue to establish, an estimated per share net asset value, or Estimated Per Share NAV, on at least an annual basis. Each Estimated Per Share NAV was determined by the Board, after consultation with an independent third-party valuation firm. The Estimated Per Share NAV is not subject to audit by our independent registered public accounting firm. The Estimated Per Share NAV was calculated for purposes of assisting broker-dealers participating in public offerings in meeting their customer account statement reporting obligations under the National Association of Securities Dealers Conduct Rule 2340. The following table outlines the established Estimated Per Share NAV as determined by the Board for the last three years as of each valuation date presented below:
Valuation DateEffective DateEstimated Per Share NAV
May 31, 2021July 26, 2021$9.95
(1)
May 31, 2021July 26, 2021$8.20
(1)
June 30, 2022August 25, 2022$8.22
March 31, 2023May 11, 2023$8.13

October 31, 2023December 18, 2023$7.48
(1)On July 22, 2021, we announced the Estimated Per Share NAV that the Board, at the recommendation of our audit committee, or the Audit Committee, approved on July 20, 2021, which was calculated as of May 31, 2021, of $9.95. Upon the declaration of a special cash distribution of $1.75 per share to stockholders of record on July 26, 2021, the new Estimated Per Share NAV was $8.20.
Key Developments During 2023
During the year ended December 31, 2023, we purchased two operating healthcare properties, comprising approximately 130,000 rentable square feet for an aggregate purchase price of approximately $69,822,000.
2

Table of Contents
During the year ended December 31, 2023, we sold three healthcare facilities for an aggregate sale price of $271,107,000 and generated net proceeds of $270,306,000.
Investment Objectives and Policies
Our primary investment objectives at this time are to:
acquire high quality healthcare properties leased to tenants along the continuum of care, capitalizing on critical and structural economic growth drivers;
pay regular cash distributions to stockholders;
preserve, protect and return capital contributions to stockholders;
realize appreciated growth in the value of our investments upon the sale of such investments in whole or in part; and
be prudent, patient and deliberate with respect to the purchase and sale of our investments considering current and projected real estate markets.
We cannot assure stockholders that we will attain these objectives or that the value of our assets will not decrease. Furthermore, within our investment objectives and policies, we have substantial discretion with respect to the selection of specific investments and the purchase and sale of our assets, subject to the approval of the Board. The Board may revise our investment objectives and policies if it determines that it is in the best interest of our stockholders.
Investment Strategy
We focus our investment activities on acquiring properties, preferably on a net-leased basis, that are primarily in the healthcare sector. We currently expect that most of our properties will continue to be located throughout the continental United States; however, we may purchase properties in other jurisdictions. We may also invest in real estate-related debt and equity securities that meet our investment strategy and return criteria. We evaluate our assets in an effort to avoid any investments that would cause us to fail to maintain our REIT status or cause us or any of our subsidiaries to be an investment company under the Investment Company Act of 1940.
We seek to obtain investments that are (i) essential to the successful business operations of the tenants; (ii) leased to creditworthy and investment grade tenants, preferably on a net-leased basis; (iii) leased to tenants on a long-term basis, which typically include annual or periodic fixed rental increases; and (iv) located in geographically diverse, established markets with superior access and visibility.
We may acquire properties in various stages of development or that require substantial refurbishment or renovation. This determination is made based upon a variety of factors, including the available risk-adjusted returns for such properties when compared with other available properties, the effect such properties would have on the diversification of our portfolio, and our investment objectives of realizing both current income and capital appreciation upon the sale of such properties.
We endeavor to achieve a well-balanced portfolio of real estate investments that is diversified by tenancy, geographic location, age and lease maturities. We seek to acquire properties primarily in the high-growth healthcare sector and tenants of the properties that are diversified between national, regional and local entities.
Creditworthy Tenants
We expect the tenants and/or sponsors of the tenants of our healthcare properties to be creditworthy national or regional companies generally with high net worth and high operating income.
A tenant is considered creditworthy if it has a financial profile that we believe meets our criteria. In evaluating the creditworthiness of a current tenant or a prospective tenant, we consider various factors, including, but not limited to, the proposed terms of the property acquisition, the financial condition of the tenant and/or the sponsor, the operating history of the property with the tenant, the tenant’s market share and track record within its industry segment, the general health and outlook of the tenant’s industry segment, and the lease length and other lease terms at the time of the property acquisition.
We monitor the credit of our tenants in an effort to stay abreast of any material changes in credit quality. We monitor tenant credit by: (1) reviewing the credit ratings of tenants (or their parent companies) that are rated by nationally recognized rating agencies; (2) reviewing financial statements that are publicly available or that are required to be delivered to us under the applicable lease; (3) monitoring industry reports and other available information regarding our tenants and their underlying businesses; (4) monitoring the timeliness of rent collections; and (5) conducting periodic inspections of our properties to ascertain proper maintenance, repair and upkeep.
3

Table of Contents
Investment Decisions
In evaluating investments in properties, we consider various factors, including, to the extent such information is available with respect to such property, the following:
proposed purchase price, terms and conditions;
physical condition, age, and environmental reports;
location, visibility and access;
historical financial performance;
tenants in place and tenant creditworthiness;
lease terms, including rent, rent increases, length of lease term, specific tenant and landlord responsibilities, renewal, expansion, termination, purchase options, exclusive and permitted uses provisions, assignment and sublease provisions, and co-tenancy requirements;
local market economic conditions, demographics and population growth patterns;
neighboring properties; and
potential for new property construction in the area.
Investing in and Originating Loans
Our criteria for originating or acquiring loans are substantially the same as those involved in our investment in properties. We may invest in mortgage, bridge or mezzanine loans. Further, we may invest in unsecured loans or loans secured by assets other than real estate.
Our underwriting process typically involves comprehensive financial, structural, operational and legal due diligence.
We may originate loans from mortgage brokers or personal solicitations of suitable borrowers, or we may purchase existing loans that were originated by other lenders. We evaluate all potential loan investments to decide whether the term of the loan, the security for the loan and the loan-to-value ratio meet our investment criteria and objectives.
Investing in Real Estate Securities
We may invest in non-majority owned securities of both publicly-traded and private companies primarily engaged in real estate businesses, including REITs and other real estate operating companies, and securities issued by pass-through entities of which substantially all of the assets consist of qualifying assets or real estate-related assets. We may purchase the common stock, preferred stock, debt, or other securities of these entities or options to acquire such securities.
Acquisition Structure
We have and expect to continue to acquire fee interests in properties (a fee interest is the absolute, legal possession and ownership of land, property, or rights), although we may utilize other methods of acquiring a property if we deem them to be advantageous.
In an effort to achieve our investment objectives, and to further diversify our portfolio, we have invested and expect to continue to invest in properties using various acquisition structures, which could include direct and indirect acquisitions, joint ventures, leveraged investments, issuing units in our Operating Partnership in exchange for properties and making mortgages or other loans secured by the same types of properties which we may acquire.
Joint Ventures
We may enter into joint ventures, partnerships and other co-ownership partnerships for the purpose of making investments. Some of the potential reasons to enter into a joint venture may be to acquire assets we could not otherwise acquire, to reduce our capital commitment to a particular asset, or to benefit from certain expertise a partner might have. In determining whether to invest in a particular joint venture, we evaluate the assets of the joint venture under the criteria described elsewhere in this Annual Report on Form 10-K for the selection of our investments. We also evaluate the terms of the joint venture, as well as the financial condition, operating capabilities and integrity of our partner or partners.
Disposition Policy
We typically intend to hold each asset we acquire for an extended period of time. However, circumstances may arise that could result in the sale of some assets earlier than initially expected. The determination of whether an asset will be sold or otherwise disposed of is made after consideration of relevant factors, including prevailing economic conditions, specific real
4

Table of Contents
estate market conditions, tax implications for our stockholders, and other factors. The requirements for qualification as a REIT for federal income tax purposes may put some limits on our ability to sell assets after short holding periods.
Financing Strategy and Policies
We believe that utilizing borrowing is consistent with our investment objectives and has the potential to maximize returns to our stockholders. Financing for acquisitions and investments may be obtained at the time an asset is acquired or an investment is made or at a later time. In addition, debt financing may be used from time to time for property improvements, tenant improvements, leasing commissions and other working capital needs. The form of our indebtedness will vary and could be long-term or short-term, secured or unsecured, or fixed-rate or floating rate. We will not enter into interest rate swaps or caps, or similar hedging transactions or derivative arrangements for speculative purposes, but may do so in order to manage or mitigate our interest rate risk on variable rate debt.
Distribution Policy
The amount of distributions we pay to our stockholders is determined by the Board and is dependent on a number of factors, including funds available for payment of distributions, our financial condition, capital expenditure requirements, annual distribution requirements needed to maintain our status as a REIT under the Code and restrictions imposed by our organizational documents and Maryland law.
We currently pay, and intend to continue to pay, distributions to our stockholders. If we do not have enough cash from operations to fund distributions, we may sell assets or draw on our credit facility in order to fund distributions. We have paid, and may continue to pay, distributions from sources other than from our cash flows from operations.
In accordance with our organizational documents and Maryland law, we may not make distributions that would: (1) cause us to be unable to pay our debts as they become due in the ordinary course of business; (2) cause our total assets to be less than the sum of our total liabilities plus senior liquidation preferences, if any; or (3) jeopardize our ability to maintain our qualification as a REIT.
To the extent that distributions to our stockholders are paid out of our current or accumulated earnings and profits, such distributions are taxable as ordinary income. To the extent that our distributions exceed our current and accumulated earnings and profits, such amounts constitute a return of capital to our stockholders for federal income tax purposes, to the extent of their basis in their stock, and thereafter will constitute a capital gain.
Competition
As we purchase properties for our portfolio, we are in competition with other potential buyers (some of whom have more cash, available liquidity, and/or offer competitive advantages versus us in the acquisition of properties) for the same properties and may have to pay more to purchase the property than if there were no other potential acquirers, or we may have to locate another property that meets our investment criteria. Although we generally acquire properties subject to existing leases, the leasing of real estate is highly competitive in the current market, and we may experience competition for tenants from owners and managers of competing projects. As a result, we may have to provide free rent, incur charges for tenant improvements, or offer other inducements, or we might not be able to timely lease the space, all of which may have an adverse impact on our results of operations. At the time we determine to dispose of our properties, we are typically in competition with sellers of similar properties to locate suitable purchasers for our properties.
Concentration of Credit Risk and Significant Tenants
As of December 31, 2023, we had cash on deposit in certain financial institutions that had deposits in excess of current federally insured levels. We limit cash investments to financial institutions with high credit standing; therefore, we do not believe we are exposed to any significant credit risk on our cash deposits. To date, we have not experienced any loss of or lack of access to cash in our accounts.
The following table shows the tenant that accounted for 10% or more of our rental revenue for the year ended December 31, 2023:
TenantTotal Number
of Leases
Leased Sq Ft2023 Rental Revenue
(in thousands)
Percentage of
2023 Rental Revenue
Post Acute Medical, LLC, and its affiliates (1)
15 708,817 $27,342 14.5 %

(1)    The leases are with tenants under the common control of Post Acute Medical, LLC and its affiliates and have lease expiration dates between 2030 and 2042.
5

Table of Contents
The following table shows the geographic diversification of our real estate properties that accounted for 10% or more of our rental revenue for the year ended December 31, 2023:
LocationTotal Number
of Leases
Leased Sq Ft2023 Rental Revenue
(in thousands)
Percentage of
2023 Rental Revenue
Houston-Pasadena-The Woodlands, TX5490,742 $19,217 10.2 %
Compliance with Governmental Regulations
Our real estate properties are subject to various federal, state and local regulatory laws and requirements, including, but not limited to, zoning regulations, building codes and land use laws and building, accessibility, occupancy and other permit requirements. Noncompliance could result in the imposition of governmental fines or an award of damages to private litigants. While we believe that we are currently in material compliance with these regulatory requirements, the requirements may change or new requirements may be imposed that could require significant unanticipated expenditures by us. Significant regulatory requirements include the laws and regulations described below.
REIT Laws and Regulations
We elected, and qualify, to be taxed as a REIT under Sections 856 through 860 of the Code. To maintain our qualification as a REIT, we must meet certain organizational and operational requirements, including a requirement to currently distribute at least 90.0% of our REIT taxable income, without regard to the deduction for dividends paid and excluding net capital gain, to our stockholders. As a REIT, we generally will not be subject to federal income tax on taxable income that we distribute to our stockholders.
If we fail to maintain our qualification as a REIT in any taxable year, we would then be subject to federal income taxes on our taxable income at regular corporate rates and would not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost, unless the Internal Revenue Service grants us relief under certain statutory provisions. Such an event could have a material adverse effect on our net income and net cash available for distribution to our stockholders.
Environmental Laws and Regulations
All real estate properties and the operations conducted on the real estate properties are subject to federal, state and local laws and regulations relating to environmental protection and human health and safety. In connection with ownership and operation of real estate, we may be potentially liable for costs and damages related to environmental matters.
Corporate Responsibility
We are committed to maintaining healthy, prosperous, and sustainable communities through thoughtful stewardship of the environment and conscientious management of our own corporate culture. In early 2022, the Board established the Environmental, Social and Governance Steering Committee, or the ESG Steering Committee, led by members of our management team and other senior managers. The ESG Steering Committee meets at least quarterly to discuss our strategy, initiatives, and progress, in support of our on-going commitment to corporate governance, social responsibility, environmental matters, sustainability, health and safety.
Environmental
In light of climate concerns and employees' continuing desire for workplace flexibility, we maintain a hybrid workplace model. We lease Class A Office space in a recently constructed building that intends to deliver a restorative professional environment that cultivates productivity, collaboration, engagement, and balance. The neighborhood in which the office building is located is part of a community that has achieved the WELL Design & Operations designation under the WELL Community Standard, the first neighborhood to do so in North America. The WELL Building Standard takes a holistic approach to health in the built environment addressing behavior, operations and design. The building is WELL Gold v2 Certified and LEED Silver Certified.
We intend to take all reasonable steps to fully comply with environmental laws and regulations for our real estate properties, including obtaining environmental assessments of all properties that we acquire. We obtain Phase I Environmental Assessment Reports, and as needed, further environmental due diligence, including but not limited to Phase II Environmental Assessment Reports, upon each property acquisition, and, if determined necessary, during our period of ownership, to ensure that the properties that we acquire and own are free of environmental contamination and hazardous substances. We also carry environmental liability insurance on our properties, which provides coverage for pollution liability, for third-party bodily injury and property damage claims.
6

Table of Contents
Social and Governance
Corporate Culture: Our strong tone at the top begins with the Board, which has demonstrated its focus on advancing openness, honesty, fairness and integrity within the Company. Ethical behavior is an important cornerstone of our Company’s continued success and each of us has an obligation to report any accounting irregularity, theft, discrimination, harassment or other violation of the law. We are committed to creating an open and accountable workplace where employees feel empowered to speak up and raise issues. With this in mind, we provide multiple channels to speak up, ask for guidance, and report concerns. We continue to prioritize having "The Right People, In The Right Places, Doing The Right Things."
Core Values: We believe that our employees are aligned around core values that inspire our behavior as individuals and as an organization. Our core values are essential to the Company's culture. These values are critical to the success of the Company and are aligned with the Company's mission and vision statements. They define expectations for how all employees collaborate, communicate, interact and perform their roles within the Company. They describe for each employee the expectation of a "HI ACT" and that is with humility, with integrity, with accountability, with transparent and honest communication and by embracing teamwork.
Social Impact and Community: Our mission is to engage, inspire, and empower our employees to make a positive impact on our community where we work and live. We strive to support each of our employees engaging in the community in areas in which they are passionate and supporting causes that are personally meaningful to them. Employees are encouraged to drive positive change by dedicating their time and talent to non-profit organizations. The Company has a volunteer program whereby employees are provided 24 paid hours each year to use for service to the community. In addition, the Company organizes several group volunteer opportunities each year to support our local communities and foster a culture of giving back. Our social impact programs are in support of several non-for-profit organizations.
Human Capital Resources
As of December 31, 2023, we had 48 employees. None of our employees are represented by a labor union or covered by a collective bargaining agreement. We aim to act with the highest integrity and operate with the highest ethical standards as we strive to create and maintain an inclusive work environment that values the uniqueness of each individual and his or her ideas and experiences. We endeavor to maintain workplaces that are free from discrimination or harassment on the basis of color, race, sex, national origin, ethnicity, religion, age, disability, sexual orientation, gender identification or expression, or any other status protected by applicable law. We conduct annual training designed to prevent harassment and discrimination and monitor employee conduct year-round. The basis for recruitment, hiring, development, training, compensation and advancement at the Company is qualifications, performance, skills and experience. We believe that our employees are fairly compensated, without regard to race, sex, national origin, ethnicity, religion, age, disability, sexual orientation, gender identification or expression, or any other status protected by applicable law and are routinely recognized for outstanding performance. Our compensation and benefits program is designed to attract and retain talent. We review our compensation and benefits against market and industry benchmarks to ensure they are competitive. Our employees are offered significant flexibility to meet personal and family needs.
Available Information
We electronically file our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and all amendments to those reports with the SEC. We have also filed our Registration Statements on Form S-11, Registration Statements on Form S-3, amendments to our Registration Statements and supplements to our prospectus in connection with our Offerings with the SEC. Copies of our filings with the SEC may be obtained from the SEC’s website, http://www.sec.gov. Access to these filings is free of charge. In addition, we make certain materials that are electronically filed with the SEC available at www.silarealtytrust.com as soon as reasonably practicable.
Item 1A. Risk Factors
The factors described below represent our principal risks. Other factors may exist that we do not consider to be significant based on information that is currently available or that we are not currently able to anticipate.
Risks Related to Our Corporate Structure
The limit on the number of shares a person may own may discourage a takeover that could otherwise result in a premium price to our stockholders and may hinder a stockholder's ability to dispose of his or her shares.
Our charter, with certain exceptions, authorizes our directors to take such actions as are necessary and desirable to preserve our qualification as a REIT. In this respect, among other things, unless exempted (prospectively or retroactively) by the Board, no person may own (i) more than 9.8% in value of the aggregate of our outstanding shares (of any class or series, including common shares or preferred shares) of stock, or (ii) more than 9.8% (in value or number, whichever is more
7

Table of Contents
restrictive) of the aggregate of the outstanding shares of only our common stock. This restriction may have the effect of delaying, deferring or preventing a change in control of us, including an extraordinary transaction (such as a merger, tender offer or sale of all or substantially all our assets) that might provide a premium price for holders of our common stock, and may make it more difficult for a stockholder to sell or dispose of his or her shares.
Our charter permits the Board to issue stock with terms that may subordinate the rights of common stockholders or discourage a third party from acquiring us in a manner that might result in a premium price to our stockholders.
Our charter permits the Board to issue up to 510,000,000 shares of common stock, of which 185,000,000 are designated as Class A shares, 75,000,000 are designated as Class I shares, 175,000,000 are designated as Class T shares, and 75,000,000 are designated as Class T2 shares, and 100,000,000 shares of preferred stock. Currently, we do not have any Class T2 shares of stock or preferred stock outstanding. In addition, the Board, without any action by our stockholders, may amend our charter from time to time to increase or decrease the aggregate number of shares or the number of shares of any class or series of stock that we have authority to issue. The Board may classify or reclassify any unissued common stock or preferred stock into other classes or series of stock and establish the preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends or other distributions, qualifications and terms and conditions of repurchase of any such stock. Thus, if also approved by a majority of our independent directors not otherwise interested in the transaction, who will have access, at our expense, to our legal counsel or independent legal counsel, the Board could authorize the issuance of additional preferred stock with terms and conditions that could have a priority as to distributions and amounts payable upon liquidation over the rights of the holders of our common stock. Preferred stock could also have the effect of delaying, deferring or preventing a change in control of us, including an extraordinary transaction (such as a merger, tender offer or sale of all or substantially all our assets) that might provide a premium price for holders of our common stock.
Our stockholders’ interest in us will be diluted if we issue additional shares.
Existing stockholders do not have preemptive rights to any shares issued by us in the future. Our charter authorizes 610,000,000 shares of stock, of which 510,000,000 shares are classified as common stock and 100,000,000 are classified as preferred stock. Subject to any limitations set forth under Maryland law, the Board may increase the number of authorized shares of stock, increase or decrease the number of shares of any class or series of stock designated, or reclassify any unissued shares without the necessity of obtaining stockholder approval. All such shares may be issued in the discretion of the Board. Therefore, existing stockholders would experience dilution of their equity investment in us if we (i) sell additional shares in the future, including those issued pursuant to our DRIP Offering, (ii) sell securities that are convertible into shares of our common stock, (iii) issue shares of our common stock in a private offering of securities to institutional investors, (iv) issue restricted shares of our common stock to our independent directors and employees, or (v) issue shares of our common stock in a merger or to sellers of properties acquired by us in connection with an exchange of limited partnership interests of our Operating Partnership. Because the limited partnership interests of our Operating Partnership may, in the discretion of the Board, be exchanged for shares of our common stock, any merger, exchange or conversion between our Operating Partnership and another entity ultimately could result in the issuance of a substantial number of shares of our common stock, thereby diluting the percentage ownership interest of other stockholders. Because of these and other reasons, our stockholders may experience substantial dilution in their percentage ownership of our shares.
We may be unable to maintain cash distributions or increase distributions over time.
There are many factors that can affect the availability and timing of cash distributions to stockholders. The amount of cash available for distributions is affected by many factors, such as our ability to buy properties, rental income from such properties and our operating expense levels, as well as many other variables. Actual cash available for distributions may vary substantially from estimates. We cannot assure our stockholders that we will be able to maintain our current level of distributions or that distributions will increase over time.
Provisions of the Maryland General Corporation Law, or the MGCL, and of our charter and bylaws could deter takeover attempts and have an adverse impact on a stockholder’s ability to exit the investment.
The MGCL, our charter, and our bylaws contain provisions that may discourage, delay or make more difficult a change in control of the Company.
We are subject to the Maryland Business Combination Act, which may discourage third parties from trying to acquire control of us and increase the difficulty of consummating such an offer.
In addition, with some exceptions, the Maryland Control Share Acquisition Act, provides that a holder of "control shares" of a Maryland corporation acquired in a control share acquisition has no voting rights, except to the extent approved by a vote of stockholders entitled to cast two-thirds of the votes entitled to be cast on the matter, excluding "control shares" owned by the acquiring person, owned by the Company's officers, and owned by the Company's employees who are also directors. As permitted by the MGCL, however, our bylaws exempt the Company from the application of the Maryland Control Share
8

Table of Contents
Acquisition Act. If we amend our bylaws to repeal this exemption, the Maryland Control Share Acquisition Act would apply and would very likely make it more difficult for a third party to obtain control of us and increase the difficulty of consummating such an offer. Further, the “unsolicited takeover” provisions of Title 3, Subtitle 8 of the MGCL permit the Board, without stockholder approval and regardless of what is provided in our charter or bylaws, to implement certain takeover defenses, including adopting a classified board or increasing the vote required to remove a director.
These provisions, as well as other provisions of our charter and bylaws, may delay, defer, or prevent a transaction or a change in control that might otherwise be in the best interests of our stockholders.
General Risks Related to Investments in Real Estate
Our operating results may be affected by economic and regulatory changes that have an adverse impact on the real estate market in general, which may prevent us from being profitable or from realizing growth in the value of our real estate properties.
Our operating results are subject to risks generally incident to the ownership of real estate, which may prevent us from being profitable, realizing growth or maintaining the value of our real estate properties, including: changes in general economic or local conditions including inflationary and/or recessionary conditions; tenant turnover, technological changes and changes in supply of or demand for similar or competing properties in an area; changes in the cost or availability of insurance; changes in interest rates and availability of permanent mortgage funds that may render the sale of a property difficult or unattractive; changes in tax, real estate, environmental and zoning laws; and periods of high interest rates and tight money supply.
If a tenant declares bankruptcy, we may be unable to collect balances due under relevant leases, which would reduce our cash flow from operations and the amount available for distributions to our stockholders.
Any of our tenants, or any guarantor of a tenant’s lease obligations, could be subject to a bankruptcy proceeding. Such a bankruptcy filing would bar all efforts by us to collect pre-bankruptcy debts from these entities or their properties, unless we receive an enabling order from the bankruptcy court. Post-bankruptcy debts would be paid currently. If a lease is assumed, all pre-bankruptcy balances owing under it must be paid in full. If a lease is rejected by a tenant in bankruptcy, we would have a general unsecured claim for damages. If a lease is rejected, it is unlikely we would receive any material payments from the tenant because our claim is capped at the rent reserved under the lease, without acceleration, for the greater of one year or 15% of the remaining term of the lease, but not greater than three years, plus rent already due but unpaid. This claim could be paid only if funds were available, and then only in the same percentage as that realized on other unsecured claims.
A tenant or lease guarantor bankruptcy could delay efforts to collect past due balances under the relevant leases, and could ultimately preclude full collection of these sums. Such an event could cause a decrease or cessation of rental payments that would mean a reduction in our cash flow and the amount available for distributions to our stockholders. In the event of a bankruptcy, we cannot give assurance that the tenant or its trustee will assume our lease. If a given lease, or guaranty of a lease, is not assumed, our cash flow and the amounts available for distributions to our stockholders may be adversely affected.
GenesisCare USA, Inc. and its affiliates, or GenesisCare, a sponsor and owner of the tenant in 17 of our real estate properties, announced that it filed for Chapter 11 bankruptcy protection under the United States Bankruptcy Code on June 1, 2023. GenesisCare emerged from bankruptcy on February 16, 2024. The master lease related to our 17 properties was assumed by the emerging entity and therefore remains in force under its existing terms. Although GenesisCare continues to make its lease payments to us in accordance with their contractual terms, we continue to negotiate with GenesisCare regarding certain adjustments to this lease and there can be no assurances that GenesisCare will continue to make its lease payments to us. At this time there can be no assurance as to how our lease negotiations will be resolved and how such negotiations may impact GenesisCare's obligations under the lease, as further discussed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7, of this Annual Report on Form 10-K.
We are subject to risks related to tenant concentration, and an adverse development with respect to a large tenant could materially and adversely affect us.
We had one exposure to tenant concentration that accounted for 10.0% or more of rental revenue for the year ended December 31, 2023. The leases with tenants under common control of Post Acute Medical LLC accounted for 14.5% of rental revenue for the year ended December 31, 2023. In the event that a tenant that occupies a significant number of our properties or whose lease payments represent a significant portion of our rental revenue were to experience financial difficulty or file for bankruptcy, it could have a material adverse effect on us. As discussed above, GenesisCare, a sponsor and owner of the tenant in 17 of our real estate properties, filed for Chapter 11 bankruptcy protection on June 1, 2023. Although GenesisCare’s bankruptcy proceeds did not have a material adverse effect on our business, there can be no assurance that similar proceedings will not cause such a material adverse effect in the future.
9

Table of Contents
A high concentration of our properties in a particular geographic area would magnify the effects of downturns or natural disasters in that geographic area.
There is a geographic concentration of risk subject to fluctuations in the economies of the various metropolitan statistical area, or MSA's, in which we own properties. Geographic concentration of our properties exposes us to risks related to or arising from economic downturns or natural disasters in the areas where our properties are located. A regional or local recession or a natural disaster in any of these areas could adversely affect our ability to generate or increase operating revenues, attract new tenants or dispose of unproductive properties.
Our investments in properties where the underlying tenant has a below investment grade credit rating, as determined by major credit rating agencies, or unrated tenants, may have a greater risk of default and therefore may have an adverse impact on our returns on that asset and our operating results.
During the year ended December 31, 2023, approximately 44.3% of our total rental revenue was derived from tenants that had an investment grade credit rating from a major ratings agency, or an investment grade rated guarantor or affiliate, 6.2% of our total rental revenue was derived from tenants that were rated but did not have an investment grade credit rating from a major ratings agency and 49.5% of our total rental revenue was derived from tenants that were not rated. Our investments with tenants that do not have an investment grade credit rating from a major ratings agency or were not rated and are not affiliated with companies having an investment grade credit rating may have a greater risk of default and bankruptcy than investments in properties leased exclusively to investment grade tenants. When we invest in properties where the tenant does not have a publicly available credit rating, we use certain credit assessment tools and rely on our own estimates of the tenant’s credit rating which include but are not limited to reviewing the tenant’s financial information (i.e., financial ratios, net worth, revenue, cash flows, leverage and liquidity) and monitoring local market conditions. If our lender or a credit rating agency disagrees with our ratings estimates, or our ratings estimates are otherwise inaccurate, we may not be able to obtain our desired level of leverage or our financing costs may exceed those that we projected. This outcome could have an adverse impact on our returns on that asset and hence our operating results.
Properties that have vacancies for a significant period of time could be difficult to sell, which could diminish the return on our stockholders’ investment.
A property may incur vacancies either by the continued default of tenants under their leases or the expiration of tenant leases. If vacancies continue for an extended period of time, we may suffer reduced revenues, resulting in less cash to be distributed to stockholders. In addition, because properties’ market values depend principally upon the value of the properties’ leases, the resale value of properties with prolonged vacancies could suffer, which could further reduce our stockholders’ return.
We may obtain only limited warranties when we purchase a property and would have only limited recourse if our due diligence did not identify any issues that lower the value of our property.
The seller of a property often sells such property in its “as is” condition on a “where is” basis and “with all faults,” without any warranties of merchantability or fitness for a particular use or purpose. In addition, purchase agreements may contain only limited warranties, representations and indemnifications that will only survive for a limited period after the closing. The purchase of properties with limited warranties increases the risk that we may lose some or all of our invested capital in the property as well as the loss of rental income from that property.
We may be unable to secure funds for future tenant improvements or capital needs, which could adversely impact our ability to pay cash distributions to our stockholders.
When tenants do not renew their leases or otherwise vacate their space, it is usual that, in order to attract replacement tenants, we expend substantial funds for tenant improvements and tenant refurbishments to the vacated space. In addition, although we expect that our leases with tenants will require tenants to pay routine property maintenance costs, we will likely be responsible for any major structural repairs, such as repairs to the foundation, exterior walls and rooftops. If we need additional capital to improve or maintain our properties or for any other reason, we will have to obtain financing from sources such as cash flow from operations, borrowings, property sales or future equity offerings. These sources of funding may not be available on attractive terms or at all. If we cannot procure additional funding for capital improvements, our investments may generate lower cash flows or decline in value, or both.
We may not be able to sell a property at a price equal to, or greater than, the price for which we purchased such property, which may lead to a decrease in the value of our assets and a reduction in the value of shares held by our stockholders.
Some of our leases will not contain rental increases over time, or the rental increases may be less than the fair market rate at a future point in time. Therefore, the value of the property to a potential purchaser may not increase over time, which may restrict our ability to sell a property, or if we are able to sell such property, may lead to a sale price less than the price that we paid to purchase the property.
10

Table of Contents
Real estate-related taxes may increase and if these increases are not passed on to tenants, our income will be reduced.
Some local real property tax assessors may seek to reassess some of our properties as a result of our acquisition of such properties. From time to time our property taxes may increase as property values or assessment rates change or for other reasons deemed relevant by the assessors. An increase in the assessed valuation of a property for real estate tax purposes will result in an increase in the related real estate taxes on that property. Although a substantial portion of our tenant leases may permit us to pass through such tax increases to the tenants for payment, there is no assurance that renewal leases or future leases will be negotiated on the same basis. Increases not passed through to tenants will adversely affect our income, cash available for distributions, and the amount of distributions to our stockholders.
Covenants, conditions and restrictions may restrict our ability to operate our properties.
Some of our properties may be contiguous to other parcels of real property, comprising part of the same commercial center. In connection with such properties, there are significant covenants, conditions and restrictions, or CC&Rs, restricting the operation of such properties and any improvements on such properties, and related to granting easements on such properties. Moreover, the operation and management of the contiguous properties may impact such properties. Compliance with CC&Rs may adversely affect our operating costs and reduce the amount of funds that we have available to pay distributions.
Our operating results may be negatively affected by potential development and construction delays and result in increased costs and risks.
We have acquired and developed properties upon which we will construct improvements. We will be subject to uncertainties associated with re-zoning for development, environmental concerns of governmental entities and/or community groups, and our builder’s ability to build in conformity with plans, specifications, budgeted costs, and timetables. A builder’s performance also may be affected or delayed by conditions beyond the builder’s control. Delays in completion of construction could also give tenants the right to terminate preconstruction leases. We may incur additional risks when we make periodic progress payments or other advances to builders before they complete construction. These and other such factors can result in increased costs of a project or loss of our investment. In addition, we will be subject to normal lease-up risks relating to newly constructed projects. We also must rely on rental income and expense projections and estimates of the fair market value of property upon completion of construction when agreeing upon a price at the time we acquire a property. If our projections are inaccurate, we may pay too much for a property, and our return on our investment could suffer.
We may invest in unimproved real property. For purposes of this paragraph, "unimproved real property" is real property which has not been acquired for the purpose of producing rental or other operating income, has no development or construction in process and on which no construction or development is planned in good faith to commence within one year. Returns from development of unimproved properties are also subject to risks associated with re-zoning the land for development and environmental concerns of governmental entities and/or community groups. Although we intend to limit any investment in unimproved property, our stockholders’ investment nevertheless is subject to the risks associated with investments in unimproved real property.
Costs of complying with governmental laws and regulations, including those relating to environmental protection, human health and safety and disability accommodation, may adversely affect our income and the cash available for any distributions.
All real property investments and the operations conducted in connection with such investments are subject to federal, state and local laws and regulations relating to environmental protection, human health and safety and disability accommodation. Some of these laws and regulations may impose joint and several liability on customers, owners or operators for the costs to investigate or remediate contaminated properties, regardless of fault or whether the acts causing the contamination were legal. They also may impose restrictions on the manner in which real property may be used or businesses may be operated. The costs of complying with these laws and regulations may have a material adverse effect on our business, financial condition and results of operations and our ability to make distributions to our stockholders.
If we sell properties by providing financing to purchasers, defaults by the purchasers would adversely affect our cash flows.
In some instances we may sell our properties by providing financing to purchasers. When we provide financing to purchasers, we will bear the risk that the purchaser may default, which could negatively impact our cash distributions to stockholders. Even in the absence of a purchaser default, the distribution of the proceeds of sales to our stockholders, or their reinvestment in other assets, will be delayed until the promissory notes or other property we may accept upon the sale are actually paid, sold, refinanced or otherwise disposed. In some cases, we may receive initial down payments in cash and other property in the year of sale in an amount less than the selling price, and subsequent payments will be spread over a number of years. If any purchaser defaults under a financing arrangement with us, it could negatively impact our ability to pay cash distributions to our stockholders.
11

Table of Contents
Risks Associated with Investments in the Healthcare Property Sector
Our properties and tenants may be unable to compete successfully, which could result in lower rent payments, reduce our cash flows from operations and the amount available for distributions to our stockholders.
Our current and potential properties and our tenants may face competition from nearby healthcare facilities and other properties that provide comparable services. Some of our competing facilities may be owned by governmental agencies and are supported by tax revenues, and others are owned by non-profit corporations and therefore are supported to a large extent by endowments and charitable contributions and pay little or no taxes. Not all of our properties will be affiliated with non-profit corporations and receive such support. Additionally, the introduction and expansion of new stakeholders competing with traditional providers in the healthcare market and telemedicine are disrupting "agents" in the healthcare industry and could lead to decreased demand for healthcare properties and new trends in payments. The trend of increasing private equity investment in healthcare providers could also increase competition in the healthcare market. Our tenants’ failure to compete successfully with other healthcare providers could adversely affect their ability to make rental payments, which could adversely affect our rental revenues. Further, from time to time and for reasons beyond our control, referral sources, including physicians and managed care organizations, may change their lists of hospitals, physicians or other healthcare providers to which they refer patients or that are permitted to participate in the payer program. This could adversely affect our tenants’ ability to make rental payments, which could adversely affect our rental revenues. Any reduction in rental revenues resulting from the inability of our healthcare properties and our tenants to compete successfully may have a material adverse effect on our business, financial condition and results of operations and our ability to make distributions to our stockholders.
Compliance with and changes to healthcare laws and regulations could have a material adverse effect on the financial condition of our tenants and, consequently, their ability to make rent payments and meet obligations to us.
Federal, state and local laws, statutes and regulatory policies, including the Patient Protection and Affordable Care Act of 2010, Transparency in Coverage rule and the Consolidated Appropriations Act of 2021, the laws listed in the paragraph directly below, and any future changes and decisions, may impact one or more specific providers that lease space in any of our properties. In addition, many states also regulate the establishment and construction of healthcare facilities and services, and the expansion of existing healthcare facilities and services through a certificate of need, or CON, laws, which may include regulation of certain licenses, medical equipment, and capital expenditures. Similarly, tenants of our healthcare properties may become subject to legal claims that their services have resulted in patient injury or other adverse effects in violation of applicable laws, including the Federal False Claims Act. Such claims may cause our tenants to incur punitive damages arising from professional liability and general liability claims and/or become subject to governmental investigations, enforcement actions or litigation.
Healthcare provider tenants may be subject to numerous laws and regulations that regulate, among other things, quality and medical necessity of care, insurance and patient billing, the security and privacy of patient information, healthcare provider financial interests and conflicts of interest, self-referrals, price transparency, corporate practice of medicine and surprise billing. Such laws and regulations include, but are not limited to: the Medicare and Medicaid statutes; the Stark Law; the civil False Claims Act; the federal False Claims Law; the federal Anti-Kickback Statute; applicable state law prohibitions against kickbacks, fraud and abuse, patient brokering, advertising and marketing of healthcare items and services and fee splitting; state laws regulating the corporate practice of medicine; the federal Eliminating Kickbacks in Recovery Act; the Program Fraud Civil Remedies Act; the Civil Monetary Penalties Law; the Exclusion Laws; the Health Insurance Portability and Accountability Act of 1996 and applicable state laws regarding patient privacy and the security of patient health information; the Clinical Laboratory Improvement Amendments of 1988; the Travel Act; OIG compliance program elements; and all amendments thereto of the foregoing, including any regulations or decisions promulgated thereunder.
The failure to comply with these laws and regulations, or the failure to secure CON approval to undertake a desired project could adversely affect our tenants’ ability to make rent payments to us which may have an adverse effect on our business, financial condition, and results of operations, and our ability to make distributions to our stockholders.
Adverse trends in healthcare provider operations may negatively affect our lease revenues and our ability to make distributions to our stockholders.
The healthcare industry is currently experiencing, among other things: changes in the demand for and methods of delivering healthcare services, particularly as telemedicine and telehealth continue to gain popularity, as well as continued innovation and integration of technological advancements and artificial intelligence; a shift in the provision of healthcare services from inpatient to outpatient settings; changes in third party reimbursement methods and policies, including an increased focus on value-based reimbursement with downside provider risk; consolidation and pressure to integrate within the healthcare industry through acquisitions, joint ventures and managed service organizations; increased scrutiny of billing, referral, and other practices by U.S. federal and state authorities; consolidation of health insurers; competition among healthcare providers including competition for patients among healthcare providers in areas with significant unused capacity; increased
12

Table of Contents
expense for uninsured patients; increased expense arising from an older and sicker patient mix; increased liability insurance expenses; increased emphasis on compliance with privacy and security requirements related to health information; pressures on healthcare providers to control or reduce costs; staffing shortages (particularly nursing staff) and increases in wages as well as inflation in the cost of supplies; regulatory and government reimbursement uncertainty, increased price transparency resulting from the Transparency in Coverage rule and the Consolidated Appropriations Act of 2021, the Hospital Price Transparency regulation of 2021, the No Surprises Act and other healthcare reform laws and court decisions on cases challenging the legality of such laws; federal and state government plans to reduce budget deficits and address debt ceiling limits by lowering healthcare provider Medicaid payment rates; increased scrutiny of control over release of confidential patient medical information and increased attention to compliance with regulations designed to safeguard protected health information and cyberattacks on healthcare entities and their business associates (i.e., vendors who handle patient protected health information); anticipated increased scrutiny and enforcement of anti-trust laws by the Federal Trade Commission and Department of Justice Antitrust Division; and increased scrutiny of billing, referral and other practices by federal and state authorities. These factors may adversely affect demand for healthcare facilities by potential future tenants and/or the economic performance of some or all of our tenants and, in turn, our lease revenues, which may have a material adverse effect on our business, financial condition, results of operations, and our ability to make distributions to our stockholders.
Risks Associated with Debt Financing and Investments
Interest rate exposure could have a material adverse effect on our results of operations, financial condition and ability to pay distributions to stockholders at our current level.
Our revenues are generated by our leases, which typically have fixed rental rates, subject to periodic rent escalators. The generally fixed nature of revenues and the variable rate of debt obligations could create interest rate risk for us. Increases in interest rates may not be matched by increases in our rental income, which could increase our expenses and adversely affect our business, financial condition, results of operations, and our ability to make distributions to our stockholders. During inflationary periods, interest rates have historically increased, which would have a direct effect on the interest expense of our borrowings. As of December 31, 2023, we have hedged all of our variable rate debt by using interest rate swaps to effectively fix the interest rate.
We have broad authority to incur debt, and high debt levels could hinder our ability to make distributions and could decrease the value of our stockholders’ investments.
High debt levels would cause us to incur higher interest charges, would result in higher debt service payments, and could be accompanied by restrictive covenants. These factors could limit the amount of cash we have available to distribute and could result in a decline in the value of our stockholders’ investments.
We incur borrowings, which may increase our business risks, and could hinder our ability to make distributions to our stockholders.
We have obtained a credit facility and may obtain other similar financing arrangements in order to acquire properties. We may also decide to later further leverage our properties. We may pledge all or some of our real properties as security for that debt to obtain funds to acquire real properties. We may borrow if we need funds to pay a desired distribution rate to our stockholders. We may also borrow if we deem it necessary or advisable to ensure that we qualify and maintain our qualification as a REIT for federal income tax purposes. If there is a shortfall between the cash flow from our properties and the cash flow needed to service debt, then the amount available for distribution to our stockholders may be reduced.
Lenders may require us to enter into restrictive covenants relating to our operations, which could limit our ability to make distributions to stockholders at our current level.
When providing financing, a lender could impose restrictions on us that affect our distribution and operating policies, and our ability to incur additional debt. Loan documents we enter into may contain covenants that limit our ability to discontinue insurance coverage. These or other limitations may adversely affect our flexibility and limit our ability to make distributions to stockholders at our current level.
Disruptions in the credit markets could have a material adverse effect on our results of operations, financial condition and ability to pay distributions to stockholders at our current level.
In the past, domestic and international financial markets experienced significant disruptions which were brought about in large part by failures in the U.S. banking system. International conflicts and resultant U.S. response, including financial sanctions, have recently disrupted credit markets. These disruptions have severely impacted the availability of credit in the market and contributed to rising costs associated with obtaining credit. If debt financing is not available on terms and conditions we find acceptable, we may not be able to obtain financing for investments. These disruptions in the credit markets have not thus far affected our ability to borrow monies to finance the purchase of, or other activities related to, real estate assets, but they
13

Table of Contents
may do so in the future. If we are unable to borrow monies on terms and conditions that we find acceptable, we may be forced to reduce the number of properties we can purchase and/or dispose of some of our assets. These disruptions could also adversely affect the return on the properties we purchase. In addition, if we pay fees to lock in a favorable interest rate, falling interest rates or other factors could require us to forfeit these fees. All of these events could have a material adverse effect on our results of operations, financial condition and ability to pay distributions to stockholders at our current level.
U.S. Federal Income Tax Risks
Failure to maintain our qualification as a REIT would adversely affect our operations and our ability to make distributions.
In order for us to maintain our qualification as a REIT, we must satisfy certain requirements set forth in the Code and Treasury Regulations and various factual matters and circumstances that are not entirely within our control. We intend to structure our activities in a manner designed to satisfy all of these requirements. However, if certain of our operations were to be recharacterized by the Internal Revenue Service, or IRS, such recharacterization could jeopardize our ability to satisfy all of the requirements for qualification as a REIT.
If we fail to maintain our qualification as a REIT for any taxable year and we do not qualify for certain statutory relief provisions, we will be subject to U.S. federal income tax on our taxable income at corporate rates. In addition, we would generally be disqualified from treatment as a REIT for the four taxable years following the taxable year in which we lost our REIT status. Losing our REIT status would reduce our net earnings available for investment or distribution to stockholders because of the additional corporate-level tax liability. In addition, distributions to stockholders would no longer qualify for the dividends-paid deduction, and we would no longer be required to make distributions. If this occurs, we might be required to borrow funds or liquidate some investments in order to pay the applicable tax. Our failure to qualify as a REIT would adversely affect the return of stockholders' investments.
To maintain our qualification as a REIT, we must meet annual distribution requirements, which may result in us distributing amounts that may otherwise be used for our operations and which could result in our forgoing otherwise attractive investment opportunities.
To maintain the favorable tax treatment afforded to REITs under the Code, we generally will be required each year to distribute to our stockholders at least 90% of our REIT taxable income determined without regard to the dividends-paid deduction and excluding net capital gain. To the extent that we do not distribute all of our net capital gains or distribute less than 100% of our REIT taxable income, as adjusted, we will have to pay tax on the undistributed amounts at corporate tax rates. Furthermore, if we fail to distribute during each calendar year at least the sum of: (a) 85% of our ordinary income for that year; (b) 95% of our capital gain net income for that year; and (c) any undistributed taxable income from prior periods, ((a) through (c), collectively referred to as the Required Distribution), we would have to pay a 4% nondeductible excise tax on the excess of the Required Distribution over the sum of (x) the amounts that we actually distributed; and the amounts we retained and upon which we paid income tax at the corporate level. These requirements could cause us to distribute amounts that otherwise would be spent on investments in real estate assets, and it is possible that we might be required to borrow funds, possibly at unfavorable rates, or sell assets to fund these distributions. In addition, we could pay part of these required distributions in shares of our common stock, which could result in stockholders having tax liabilities from such distributions in excess of the cash they receive. It is possible the taxable share distribution will not count towards our distribution requirement, in which case adverse consequences could apply. Although we intend to continue to make distributions sufficient to meet the annual distribution requirements and to avoid U.S. federal income and excise taxes, it is possible that we might not always be able to do so.
Certain of our business activities are potentially subject to the prohibited transaction tax, which could reduce the return on our stockholders’ investment.
Our ability to dispose of a property during the first few years following its acquisition may be restricted to a substantial extent as a result of our REIT status. Under applicable provisions of the Code regarding "prohibited transactions" by REITs, we would be subject to a 100% tax on any gain recognized on the sale or other disposition of any property (other than foreclosure property) that we own, directly or through any subsidiary entity, including our Operating Partnership, that is deemed to be inventory or property held primarily for sale to customers in the ordinary course of a trade or business. Whether property is inventory or otherwise held primarily for sale to customers in the ordinary course of a trade or business depends on the particular facts and circumstances surrounding each property. Properties we own, directly or through any subsidiary entity, including our Operating Partnership, may, depending on how we conduct our operations, be treated as inventory or property held primarily for sale to customers in the ordinary course of a trade or business. Any such taxes we pay would reduce our cash available for distribution to our stockholders. Our desire to avoid the prohibited transactions tax may cause us to forego disposition opportunities that would otherwise be advantageous if we were not a REIT.
14

Table of Contents
In certain circumstances, we may be subject to U.S. federal, state and local income taxes as a REIT, which would reduce our cash available for distribution to our stockholders.
Even if we maintain our qualification as a REIT, we may be subject to U.S. federal, state and local income taxes. For example, we may be subject to the prohibited transactions tax and/or the excise tax for failing to make (or be deemed to have made) sufficient distributions, as described above. We also may decide to retain net capital gain we earn from the sale or other disposition of our property and pay income tax directly on such income. In that event, our stockholders would be treated as if they earned that income and paid the tax on it directly. However, stockholders that are tax-exempt, such as charities or qualified pension plans, would have no benefit from their deemed payment of such tax liability unless they file U.S. federal income tax returns and thereon seek a refund of such tax. We also may be subject to state and local taxes on our income or property, either directly or indirectly through our Operating Partnership or other companies through which we indirectly own assets. Any taxes we pay would reduce our cash available for distribution to our stockholders.
The use of taxable REIT subsidiaries, which may be required for REIT qualification purposes, would increase our overall tax liability and thereby reduce our cash available for distribution to our stockholders.
Some of our assets may need to be owned by, or operations may need to be conducted through, one or more taxable REIT subsidiaries. Any of our taxable REIT subsidiaries would be subject to U.S. federal, state and local income tax on its taxable income at applicable corporate rates. The after-tax net income of our taxable REIT subsidiaries would be available for distribution to us. Further, we would incur a 100% excise tax on transactions with our taxable REIT subsidiaries that are not conducted on an arm’s-length basis. For example, to the extent that the rent paid by one of our taxable REIT subsidiaries exceeds an arm’s-length rental amount, such amount would be potentially subject to a 100% excise tax. While we intend that all transactions between us and our taxable REIT subsidiaries would be conducted on an arm’s-length basis, and therefore, any amounts paid by our taxable REIT subsidiaries to us would not be subject to the excise tax, no assurance can be given that excise tax would not arise from such transactions. At this time, we have no taxable REIT subsidiaries.
Complying with REIT requirements may force us to forgo and/or liquidate otherwise attractive investment opportunities.
To qualify as a REIT for U.S. federal income tax purposes, we must continually satisfy tests concerning, among other things, the sources of our income, the nature and diversification of our assets, the amounts we distribute to our stockholders and the ownership of shares of our common stock. We may be required to forego otherwise attractive investments or make distributions to stockholders at disadvantageous times or when we do not have funds readily available for distribution. Thus, compliance with the REIT requirements may hinder our ability to operate solely on the basis of maximizing profits.
Complying with the REIT asset test requirements may force us to liquidate otherwise attractive investments.
To maintain our qualification as a REIT, we must ensure that at the end of each calendar quarter, at least 75% of the value of our assets consists of cash, cash items, government securities and qualified real estate assets, including certain mortgage loans and certain kinds of mortgage-related securities. The remainder of our investment in securities (other than government securities, taxable REIT subsidiaries and qualified real estate assets) generally cannot include more than 10% of the outstanding voting securities of any one issuer or more than 10% of the total value of the outstanding securities of any one issuer. In addition, in general, no more than 5% of the value of our assets can consist of the securities (other than government securities, taxable REIT subsidiaries, and qualified real estate assets) of any one issuer. No more than 20% of the value of our total assets can be represented by securities of one or more taxable REIT subsidiaries, and no more than 25% of the value of our assets may consist of "non-qualified publicly offered REIT instruments." If we fail to comply with these requirements at the end of any calendar quarter, we must correct the failure within 30 days after the end of the calendar quarter or qualify for certain statutory relief provisions to avoid losing our REIT qualification and suffering adverse tax consequences. As a result, we may be required to liquidate from our portfolio or not make otherwise attractive investments in order to maintain our qualification as a REIT. These actions could have the effect of reducing our income and amounts available for distribution to our stockholders.
If our leases are not considered as true leases for U.S. federal income tax purposes, we could fail to qualify as a REIT.
To qualify as a REIT, we must satisfy two gross income tests, under which specified percentages of our gross income must be derived from certain sources, such as “rents from real property.” In order for rent paid to us to qualify as “rents from real property” for purposes of the REIT gross income tests, the leases must be respected as true leases for U.S. federal income tax purposes and not be treated as service contracts, joint ventures, or some other type of arrangement. If our leases are not respected as true leases for U.S. federal income tax purposes, we could fail to qualify as a REIT, which would materially and adversely impact the value of an investment in our shares and in our ability to pay dividends to our stockholders.
Legislative or regulatory action could adversely affect the returns to our investors.
In recent years, numerous legislative, judicial and administrative changes have been made in the provisions of U.S. federal income tax laws applicable to investments similar to an investment in shares of our common stock. Additional changes to the tax laws are likely to continue to occur, and we cannot assure you that any such changes will not adversely affect our taxation
15

Table of Contents
and our ability to continue to qualify as a REIT or the taxation of a stockholder. Any such changes could have a material adverse effect on an investment in our shares or on the market value or the resale potential of our assets.
Although REITs generally receive better tax treatment than entities taxed as regular corporations, it is possible that future legislation would result in a REIT having fewer tax advantages, and it could become more advantageous for a company that invests in real estate to elect to be treated for U.S. federal income tax purposes as a regular corporation. As a result, our charter provides the Board with the power, under certain circumstances, to revoke or otherwise terminate our REIT election and cause us to be taxed as a regular corporation, without the vote of our stockholders. The Board has fiduciary duties to us and our stockholders and could only cause such changes in our tax treatment if it determines in good faith that such changes are in the best interests of our stockholders.
We urge you to consult with your own tax advisor with respect to the status of legislative, regulatory or administrative developments and proposals and their potential effect on an investment in shares of our common stock.
Dividends payable by REITs generally are subject to a higher tax rate than regular corporate dividends under current law.
The maximum U.S. federal income tax rate for “qualified dividends” payable to U.S. stockholders that are individuals, trusts and estates generally is 20%. Dividends payable by REITs, however, are generally not eligible for the reduced rates for qualified dividends and are taxed at ordinary income rates. However, for taxable years beginning after December 31, 2017, and before January 1, 2026, U.S. stockholders that are individuals, trusts and estates generally may deduct 20% of ordinary dividends from a REIT resulting in an effective maximum U.S. federal income tax rate of 29.6% on such income. These rules do not adversely affect the taxation of REITs or dividends payable by REITs, to the extent that the reduced rates continue to apply to regular corporate qualified dividends; however, investors that are individuals, trusts and estates may perceive investments in REITs to be relatively less attractive than investments in the stocks of non-REIT corporations that pay dividends, which could materially and adversely affect the value of the shares of REITs, including our common stock.
If our Operating Partnership fails to maintain its status as a partnership, its income may be subject to taxation, which would reduce the cash available for distribution to our stockholders.
We intend to maintain the status of our Operating Partnership as a partnership for U.S. federal income tax purposes. However, if the IRS were to successfully challenge the status of our Operating Partnership as a partnership or disregarded entity for such purposes, it would be taxable as a corporation. In such event, this would reduce the amount of distributions that our Operating Partnership could make to us. This would also result in our losing REIT status, and becoming subject to a corporate level tax on our own income. This would substantially reduce our cash available to pay distributions and the yield on our stockholders’ investment. In addition, if any of the partnerships or limited liability companies through which our Operating Partnership owns its properties, in whole or in part, loses its characterization as a partnership and is otherwise not disregarded for U.S. federal income tax purposes, it would be subject to taxation as a corporation, thereby reducing distributions to our Operating Partnership. Such a recharacterization of an underlying property owner could also threaten our ability to maintain REIT status and would have a material adverse impact on us.
Foreign purchasers of our shares may be subject to FIRPTA tax upon the sale of their shares or upon the payment of a capital gain dividend, which would reduce the net amount they would otherwise realize on their investment in our shares.
A foreign person (other than certain foreign pension plans and certain foreign publicly traded entities) disposing of a U.S. real property interest, including shares of a U.S. corporation whose assets consist principally of U.S. real property interests, is generally subject to the Foreign Investment in Real Property Tax Act of 1980, as amended, or FIRPTA, on the gain recognized on the disposition. Such FIRPTA tax does not apply to the disposition of stock in a REIT if the REIT is “domestically controlled.” A REIT is "domestically controlled" if less than 50% of the REIT’s stock, by value, has been owned directly or indirectly by persons who are not qualifying U.S. persons during a continuous five-year period ending on the date of disposition or, if shorter, during the entire period of the REIT’s existence. We cannot assure our stockholders that we will qualify as a "domestically controlled" REIT. If we were to fail to so qualify, any gain realized by foreign investors on a sale of our shares would be subject to FIRPTA tax, unless our shares were traded on an established securities market and the foreign investor did not at any time during a specified testing period directly or indirectly own more than 10% of the value of our outstanding common stock.
A foreign investor also may be subject to FIRPTA tax upon the payment of any capital gain dividend by us, which dividend is attributable to gain from sales or exchanges of U.S. real property interests. We encourage our stockholders to consult their own tax advisor to determine the tax consequences applicable to them if they are a foreign investor.
16

Table of Contents
ERISA Risks
If our assets are deemed to be ERISA plan assets, we may be exposed to liabilities under Title I of ERISA and the Internal Revenue Code.
In some circumstances where an Employee Retirement Income Security Act of 1974, as amended, or ERISA, plan holds an interest in an entity, the assets of the entire entity are deemed to be ERISA plan assets unless an exception applies. This is known as the "look-through rule." Under those circumstances, the obligations and other responsibilities of plan sponsors, plan fiduciaries and plan administrators, and of parties in interest and disqualified persons, under Title I of ERISA and Section 4975 of the Code, as applicable, may be applicable, and there may be liability under these and other provisions of ERISA and the Code. We believe that our assets should not be treated as plan assets because the shares should qualify as "publicly-offered securities" that are exempt from the look-through rules under applicable Treasury Regulations. We note, however, that because certain limitations are imposed upon the transferability of shares so that we may qualify as a REIT, and perhaps for other reasons, it is possible that this exemption may not apply. If that is the case, and if we are exposed to liability under ERISA or the Code, our performance and results of operations could be adversely affected. Prior to making an investment in us, you should consult with your legal and other advisors concerning the impact of ERISA and the Code on your investment and our performance.
General Risk Factors
Our shares of common stock are not listed on an exchange, and we are not required to provide for a liquidity event. Therefore, it may be difficult for stockholders to sell their shares and, if stockholders are able to sell their shares, they may sell them at a substantial discount. Our stockholders are also limited in their ability to sell their shares pursuant to our share repurchase program and may have to hold their shares for an indefinite period of time.
There is currently no public market for our shares. Although we presently intend to consider alternatives for providing liquidity to our stockholders, we do not have a fixed date or method for providing stockholders with liquidity, and our completion of a liquidity event is not guaranteed. If we do not pursue a liquidity transaction, or delay such a transaction due to market conditions, shares may continue to be illiquid and stockholders may, for an indefinite period of time, be unable to convert their investment to cash easily and could suffer losses on their investment. If our stockholders are able to find a buyer for their shares, our stockholders may have to sell them at a substantial discount to their purchase price. Moreover, investors should not rely on our share repurchase program as a method to sell shares promptly because our share repurchase program includes numerous restrictions that limit stockholders' ability to sell shares to us, and the Board may suspend (in whole or in part) the share repurchase program at any time, and may amend, reduce or terminate our share repurchase program upon 30 days' prior notice to our stockholders for any reason it deems appropriate. The restrictions of our share repurchase program limit our stockholders’ ability to sell their shares should they require liquidity and limit our stockholders’ ability to recover the value they invested. We can only repurchase shares due to death or involuntary exigent circumstance in accordance with our share repurchase program, subject in each case to specified terms and limitations, including, but not limited to, quarterly share limitations, an annual 5.0% share limitation, and DRIP funding limitations. See Part II, Item 5. "Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities" for more information on the limitations of our share repurchase program.
It may be difficult to accurately reflect material events that may impact our Estimated Per Share NAV between valuations, and accordingly we may be selling and repurchasing shares at too high or too low a price.
Estimated Per Share NAV is based on the estimated value of our assets less the estimated value of our liabilities divided by the number of shares outstanding, calculated as of a certain date. The Estimated Per Share NAV of each of our Class A common stock, Class I common stock and Class T common stock is an estimate as of a certain time and may not reflect the value that stockholders will receive for their investment. The Estimated Per Share NAV is determined by an independent third-party valuation firm, the engagement of which is approved by the Audit Committee. The Financial Industry Regulatory Authority, or FINRA, rules provide no guidance on the methodology an issuer must use to determine its estimated value per share. As with any valuation methodology, our independent valuation firm's methodology is based upon a number of estimates and assumptions that may not be accurate or complete. Some of these estimates and assumptions relate to potential, future events and expectations, so they are inherently subject to inaccuracy and differences from actual results. Different parties with different assumptions and estimates could derive a different estimated value per share, and these differences could be significant. The Estimated Per Share NAV is not audited and does not represent the fair value of our assets or liabilities according to U.S. generally accepted accounting principles, or GAAP. Accordingly, with respect to the Estimated Per Share NAV, we can give no assurance that: (i) a stockholder would be able to resell his or her shares at the Estimated Per Share NAV; (ii) a stockholder would ultimately realize distributions per share equal to the Estimated Per Share NAV upon liquidation of our assets and settlement of our liabilities or a sale of the company; (iii) our shares of common stock would trade at the Estimated Per Share NAV on a national securities exchange; (iv) a different independent third-party appraiser or other third-party
17

Table of Contents
valuation firm would agree with the Estimated Per Share NAV; or (v) the methodology used to estimate our NAV per share would be acceptable to FINRA or comply with ERISA reporting requirements.
The value of our shares will fluctuate over time in response to developments related to individual assets in the portfolio and the management of those assets and in response to the real estate and finance markets. We expect to engage an independent valuation firm to update the Estimated Per Share NAV at least annually.
Cybersecurity risks and cyber incidents may adversely affect our business by causing a disruption to our operations, a compromise or corruption of our confidential information, and/or damage to our business relationships, all of which could negatively impact our financial results.
We consider a cyber incident to be any adverse event that threatens the confidentiality, integrity or availability of our information resources. These incidents may be an intentional attack or an unintentional event and could involve gaining unauthorized access to our information systems for purposes of misappropriating assets, stealing confidential information, corrupting data or causing operational disruption. The result of these incidents may include disrupted operations, misstated or unreliable financial data, liability for stolen assets or information, increased cybersecurity protection and insurance costs, litigation and damage to our tenant and investor relationships. As our reliance on technology has increased, so have the risks posed to our information systems, both internal and those we have outsourced. There is no guarantee that any processes, procedures and internal controls we have implemented, or will implement, will prevent cybersecurity threats that could adversely affect our business, financial condition, and results of operations. Additionally, as increased regulatory compliance for cybersecurity protocols and disclosures are required by state or federal authorities, there is no guarantee that the increased amount of resources, both time and expense, will not adversely affect our business.
We expect that most of our properties will continue to be located in the continental United States and would be affected by economic downturns, as well as economic cycles and risks inherent to that area.
Our properties are concentrated in, and we expect to continue to acquire commercial real estate located in, the continental United States; however, we may purchase properties in other jurisdictions. Real estate markets are subject to economic downturns, as they have been in the past, and we cannot predict how economic conditions will impact this market in both the short and long term. Declines in the economy or a decline in the real estate market in the continental United States could hurt our financial performance and the value of our properties. The factors affecting economic conditions in the continental United States real estate market include, but are not limited to: financial performance and productivity of, among others, the publishing, advertising, financial, technology, retail, insurance and real estate industries; business layoffs or downsizing; industry slowdowns; potential government shutdowns; relocations of businesses; changing demographics; increased telecommuting and use of alternative workplaces; infrastructure quality; any oversupply of, or reduced demand for, real estate; concessions or reduced rental rates under new leases for properties where tenants defaulted; increased insurance premiums; and increased interest rates.
Distributions paid from sources other than our cash flows from operations, including from the proceeds of our Offerings, will result in us having fewer funds available for the acquisition of properties and real estate-related investments, which may adversely affect our ability to fund future distributions with cash flows from operations and may adversely affect a stockholder's overall return.
We have previously paid, and may pay in the future, distributions from sources other than from our cash flows from operations. We may pay, and have no limits on the amounts we may pay, distributions from any source, such as the sale of assets, the sale of additional securities and funds equal to amounts reinvested in the DRIP, which may reduce the amount of capital we ultimately invest in properties or other permitted investments. Funding distributions from the sale of assets may affect our ability to generate cash flows. Funding distributions from the sale of additional securities could dilute stockholders' interest in us if we sell shares of our common stock to third party investors. Funding distributions to our stockholders will result in us having less funds available for acquiring properties or real estate-related investments. Our inability to acquire such properties or investments may have a negative effect on our ability to generate sufficient cash flows from operations to pay distributions. As a result, the return investors may realize on their investment may be reduced and investors who invested in us before we generated significant cash flow may realize a lower rate of return than later investors. Payment of distributions from any of the aforementioned sources could restrict our ability to generate sufficient cash flows from operations, affect our profitability and/or affect the distributions payable upon a liquidity event, any or all of which may have an adverse effect on an investment in us.
Item 1B. Unresolved Staff Comments.
None.
18

Table of Contents
Item 1C. Cybersecurity.
We have developed, implemented, and integrated a cybersecurity program, or the Cybersecurity Program, to protect our information systems by using physical, technical, and administrative safeguards. This includes assessing, identifying, monitoring, reporting, managing and remediating cybersecurity threats. The Cybersecurity Program aims to prevent data ex-filtration, manipulation, and destruction, as well as system and transactional disruption. The Cybersecurity Program utilizes a threat-centric and risk-based approach to identify and assess cybersecurity threats that could affect our business and information systems based on the National Institute of Standards and Technology Cybersecurity Framework, or the NIST Framework.
Our Cybersecurity Program includes the following processes:
Quarterly control reviews, annual policy reviews and annual investments in our security infrastructure;
Periodic testing of our information systems to assess our vulnerability to cyber risk, which includes targeted penetration testing and vulnerability scanning;
Testing and audits of our IT-related internal controls over financial reporting, excluding cybersecurity controls, by our internal auditors;
Conducting a comprehensive information security and training program for our employees, including mandatory computer-based training, regular internal communications, and ongoing end-user testing to measure the effectiveness of our information security program. As part of this commitment, we require our employees to acknowledge our Information Security policy each year. In addition, we have an established schedule and process for regular phishing awareness campaigns that are designed to emulate real-world contemporary threats and provide immediate feedback (and, if necessary, additional training or remedial action) to employees;
Annually assess the Cybersecurity Program against the NIST Framework;
Maintaining business continuity, contingency and recovery plans to quickly react to cybersecurity incidents;
Conducting security assessments of all third-party service providers with access to personal, confidential or proprietary information before engagement and maintaining ongoing monitoring by reviewing system and organization controls reports, relevant cyber attestations, and other independent cyber ratings;
Retaining a third-party cybersecurity provider for emergency incident response services in the event of a serious information security breach; and
Maintaining cybersecurity risk insurance that could help defray the costs of an information security breach as a backstop to the Cybersecurity Program.
Through our incident response plan, we have designated a cybersecurity management committee, or the Cybersecurity Management Committee, composed of our executive officers and management representatives. Led by Our Vice President of Information Technology & Corporate Facilities, our Cybersecurity Management Committee is responsible for the management of the Cybersecurity Program and for the day-to-day investigation of and response to potential information security-related incidents. Pursuant to our incident response plan, incidents meeting specified severity levels are required to be escalated to the Cybersecurity Management Committee for review and response. The goals of the incident response plan are to prevent, detect and react to information security incidents, determine their scope and risk, respond appropriately to the incident, communicate the results and risk to relevant stakeholders, and reduce the likelihood of the incident from reoccurring.
Our Vice President of Information Technology & Corporate Facilities has served in this role since 2018, and has more than 25 years of experience in various roles involving managing information security, technology infrastructure and IT operations.
Our Board plays a role in overseeing risks associated with cybersecurity threats and has delegated to the Audit Committee primary oversight of the Cybersecurity Program. Our executive officers report on our Cybersecurity Program to both the Board and the Audit Committee at least four times per year (including as part of our discussions regarding enterprise risk management). In addition, quarterly reports to the Audit Committee include our internal auditor's reviews of our information security programs and controls. As part of the incident response plan discussed above, in the event we experience a cybersecurity incident that could materially affect us, including our business strategy, results of operations or financial condition, our executive officers (who are also a part of the Cybersecurity Management Committee) will review the incident with the Audit Committee to consider whether and to what extent disclosure is required under Item 1.05 of Form 8-K.
We face risks from cybersecurity threats that could have a material adverse effect on our business strategy, results of operations or financial conditions. See “Risk Factors – General Risk Factors - Cybersecurity risks and cyber incidents may adversely affect our business by causing a disruption to our operations, a compromise or corruption of our confidential information, and/or damage to our business relationships, all of which could negatively impact our financial results” in Part I, Item 1A of this Annual Report on Form 10-K for a discussion of these risks. To date, we have not experienced a material cybersecurity incident.
19

Table of Contents
Item 2. Properties.
Our principal executive office is located at 1001 Water Street, Suite 800, Tampa, Florida 33602. As of December 31, 2023, we owned a portfolio of 131 real estate properties, composed of approximately 5,114,000 rentable square feet of commercial spaces, and two undeveloped land parcels. As of December 31, 2023, 117 of our real estate properties were leased to a single-tenant and 14 of our real estate properties were leased to multiple tenants. As of December 31, 2023, 99.4% of our rentable square feet was leased, with a weighted average remaining lease term of 8.5 years. As of December 31, 2023, all of our real estate investments are in healthcare properties and undeveloped land parcels.
20

Table of Contents
Property Statistics
The following table shows the property statistics of our real estate portfolio as of December 31, 2023:
Property NameMSA/µSADate AcquiredYear ConstructedYear Renovated% LeasedLeased Sq FtEncumbrances,
$ (in thousands)
Houston Healthcare FacilityHouston-Pasadena-The Woodlands, TX07/31/20141993100%13,645 
(1)
Cincinnati Healthcare FacilityCincinnati, OH-KY-IN10/29/20142001100%14,868 
(1)
Winston-Salem Healthcare FacilityWinston-Salem, NC12/17/20142004100%22,200 
(1)
Stoughton Healthcare FacilityBoston-Cambridge-Newton, MA-NH12/23/201419731997100%180,744 
(1)
Fort Worth Healthcare FacilityDallas-Fort Worth-Arlington, TX12/31/20142014100%83,464 
(1)
Fort Worth Healthcare Facility IIDallas-Fort Worth-Arlington, TX12/31/20142014100%8,268 
(1)
Winter Haven Healthcare FacilityLakeland-Winter Haven, FL01/27/20152009100%7,560 
(1)
Overland Park Healthcare FacilityKansas City, MO-KS02/17/20152014100%54,568 
(1)
Clarion Healthcare FacilityPittsburgh, PA06/01/20152012100%33,000 
(1)
Webster Healthcare FacilityHouston-Pasadena-The Woodlands, TX06/05/20152015100%53,514 
(1)
Augusta Healthcare FacilityAugusta-Waterville, ME (µSA)07/22/20152010100%51,000 
(1)
Cincinnati Healthcare Facility IIICincinnati, OH-KY-IN07/22/20152014100%41,600 
(1)
Florence Healthcare FacilityCincinnati, OH-KY-IN07/22/20152014100%41,600 
(1)
Oakland Healthcare FacilityAugusta-Waterville, ME (µSA)07/22/20152004100%20,000 
(1)
Wyomissing Healthcare FacilityPhiladelphia-Camden-Wilmington, PA-NJ-DE-MD07/24/20152007100%33,217 
(1)
Luling Healthcare FacilityAustin-Round Rock-San Marcos, TX07/30/20152003100%40,901 
(1)
Omaha Healthcare FacilityOmaha, NE-IA10/14/20152014100%40,402 
(1)
Sherman Healthcare FacilitySherman-Denison, TX11/20/201520052010100%57,576 
(1)
Sherman Healthcare Facility IISherman-Denison, TX11/20/20152005100%8,055 
(1)
Fort Worth Healthcare Facility IIIDallas-Fort Worth-Arlington, TX12/23/201519982007/2015100%36,800 
(1)
Oklahoma City Healthcare FacilityOklahoma City, OK12/29/201519851998/2003100%94,076 
(1)
Oklahoma City Healthcare Facility IIOklahoma City, OK12/29/201519941999100%41,394 
(1)
Edmond Healthcare FacilityOklahoma City, OK01/20/20162002100%17,700 
(1)
Oklahoma City Healthcare Facility IIIOklahoma City, OK01/27/20162006100%5,000 
(1)
Oklahoma City Healthcare Facility IVOklahoma City, OK01/27/20162007100%8,762 
(1)
Newcastle Healthcare FacilityOklahoma City, OK02/03/201619951999100%7,424 
(1)
Oklahoma City Healthcare Facility VOklahoma City, OK02/11/20162008100%43,676 
(1)
Rancho Mirage Healthcare FacilityRiverside-San Bernardino-Ontario, CA03/01/20162018100%47,008 
(1)
Oklahoma City Healthcare Facility VIOklahoma City, OK03/07/20162007100%14,676 
(1)
Oklahoma City Healthcare Facility VIIOklahoma City, OK06/22/20162016100%102,978 
(1)
Las Vegas Healthcare FacilityLas Vegas-Henderson-North Las Vegas, NV06/24/20162017100%56,220 
(1)
Oklahoma City Healthcare Facility VIIIOklahoma City, OK06/30/201619972008100%62,857 
(1)
Marlton Healthcare FacilityPhiladelphia-Camden-Wilmington, PA-NJ-DE-MD11/01/20161995100%89,139 
(1)
Grand Rapids Healthcare FacilityGrand Rapids-Wyoming-Kentwood, MI12/07/2016200884%90,150 
(1)
Corpus Christi Healthcare FacilityCorpus Christi, TX12/22/201619922016100%25,102 
(1)
Aurora Healthcare FacilityChicago-Naperville-Elgin, IL-IN03/30/20172002100%24,722 
(1)
Allen Healthcare FacilityDallas-Fort Worth-Arlington, TX03/31/20172007100%42,627 
(1)
Austin Healthcare FacilityAustin-Round Rock-San Marcos, TX03/31/20172012100%66,095 
(1)
Beaumont Healthcare FacilityBeaumont-Port Arthur, TX03/31/20171991100%61,000 
(1)
San Antonio Healthcare FacilitySan Antonio-New Braunfels, TX06/29/20171984
(2)
100%44,746 
(1)
Silverdale Healthcare FacilityBremerton-Silverdale-Port Orchard, WA08/25/20172005100%26,127 
(1)
Silverdale Healthcare Facility IIBremerton-Silverdale-Port Orchard, WA09/20/20172007100%19,184 
(1)
Saginaw Healthcare FacilitySaginaw, MI12/21/20172002100%87,843 
(1)
Carrollton Healthcare FacilityDallas-Fort Worth-Arlington, TX04/27/20182015100%21,990 
(1)
Katy Healthcare FacilityHouston-Pasadena-The Woodlands, TX06/08/20182015100%34,296 
(1)
Indianola Healthcare FacilityDes Moines-West Des Moines, IA09/26/20182014100%18,116 
(1)
21

Table of Contents
Property NameMSA/µSADate AcquiredYear ConstructedYear Renovated% LeasedLeased Sq FtEncumbrances,
$ (in thousands)
Indianola Healthcare Facility IIDes Moines-West Des Moines, IA09/26/20182011100%20,990 
(1)
Benton Healthcare FacilityLittle Rock-North Little Rock-Conway, AR10/17/20181992/19992012100%104,419 
(1)
Benton Healthcare Facility IILittle Rock-North Little Rock-Conway, AR10/17/20181983100%11,350 
(1)
Bryant Healthcare FacilityLittle Rock-North Little Rock-Conway, AR10/17/20181995100%23,450 
(1)
Hot Springs Healthcare FacilityLittle Rock-North Little Rock-Conway, AR10/17/20182009100%8,573 
(1)
Clive Healthcare FacilityDes Moines-West Des Moines, IA11/26/20182008100%58,156 
(1)
Valdosta Healthcare FacilityValdosta, GA11/28/20182004100%24,750 
(1)
Valdosta Healthcare Facility IIValdosta, GA11/28/20181992100%12,745 
(1)
Bryant Healthcare Facility IILittle Rock-North Little Rock-Conway, AR 08/16/20192016100%16,425 
(1)
Laredo Healthcare FacilityLaredo, TX09/19/201919982023100%61,677 
(1)
Laredo Healthcare Facility IILaredo, TX09/19/20191998100%118,132 
(1)
Poplar Bluff Healthcare FacilityPoplar Bluff, MO (µSA)09/19/20192013100%71,519 
(1)
Tucson Healthcare FacilityTucson, AZ09/19/20191998100%34,009 
(1)
Akron Healthcare FacilityAkron, OH 10/04/20192012100%98,705 
(1)
Akron Healthcare Facility IIAkron, OH 10/04/20192013100%38,564 
(1)
Akron Healthcare Facility IIIAkron, OH 10/04/20192008100%54,000 
(1)
Alexandria Healthcare FacilityAlexandria, LA 10/04/20192007100%15,600 
(1)
Appleton Healthcare FacilityAppleton, WI 10/04/20192011100%7,552 
(1)
Austin Healthcare Facility IIAustin-Round Rock-San Marcos, TX10/04/20192006100%18,273 
(1)
Bellevue Healthcare FacilityGreen Bay, WI 10/04/20192010100%5,838 
(1)
Bonita Springs Healthcare FacilityCape Coral-Fort Myers, FL 10/04/201920022005100%9,800 
Bridgeton Healthcare FacilitySt. Louis, MO-IL 10/04/20192012100%66,914 
(1)
Covington Healthcare FacilityNew Orleans-Metairie, LA 10/04/20191984100%43,250 
(1)
Crestview Healthcare FacilityCrestview-Fort Walton Beach-Destin, FL 10/04/201920042010100%5,685 
Dallas Healthcare FacilityDallas-Fort Worth-Arlington, TX 10/04/20192011100%62,390 
(1)
De Pere Healthcare FacilityGreen Bay, WI 10/04/20192005100%7,100 
(1)
Denver Healthcare FacilityDenver-Aurora-Centennial, CO10/04/201919622018100%131,210 
(1)
El Segundo Healthcare FacilityLos Angeles-Long Beach-Anaheim, CA 10/04/20192009100%12,163 
Fairlea Healthcare FacilityHagerstown-Martinsburg, MD-WV 10/04/20191999100%5,200 
Fayetteville Healthcare FacilityFayetteville-Springdale-Rogers, AR10/04/201919942009100%55,740 
(1)
Fort Myers Healthcare FacilityCape Coral-Fort Myers, FL 10/04/20191999100%32,148 
Fort Myers Healthcare Facility IICape Coral-Fort Myers, FL 10/04/201920102022100%47,089 
Fort Walton Beach Healthcare FacilityCrestview-Fort Walton Beach-Destin, FL 10/04/20192005100%9,017 
Frankfort Healthcare FacilityLexington-Fayette, KY 10/04/201919932019100%4,000 
Frisco Healthcare FacilityDallas-Fort Worth-Arlington, TX 10/04/201920102020100%57,051 
(1)
Goshen Healthcare FacilityElkhart-Goshen, IN 10/04/20192010100%15,462 
(1)
Hammond Healthcare FacilityHammond, LA 10/04/20192006100%63,000 
(1)
Hammond Healthcare Facility IIHammond, LA 10/04/20192004100%23,835 
(1)
Henderson Healthcare FacilityLas Vegas-Henderson-North Las Vegas, NV10/04/20192000100%6,685 
Houston Healthcare Facility IIIHouston-Pasadena-The Woodlands, TX10/04/201919982018100%16,217 
(1)
Howard Healthcare FacilityGreen Bay, WI 10/04/20192011100%7,552 
(1)
Jacksonville Healthcare FacilityJacksonville, FL 10/04/20192009100%13,082 
Lafayette Healthcare FacilityLafayette, LA 10/04/201920042005100%73,824 
(1)
Lakewood Ranch Healthcare FacilityNorth Port-Bradenton-Sarasota, FL10/04/20192008100%10,919 
Las Vegas Healthcare Facility IILas Vegas-Henderson-North Las Vegas, NV10/04/20192007100%6,963 
Lehigh Acres Healthcare FacilityCape Coral-Fort Myers, FL 10/04/20192002100%5,746 
Lubbock Healthcare FacilityLubbock, TX 10/04/20192003100%102,143 
(1)
Manitowoc Healthcare FacilityGreen Bay, WI 10/04/20192003100%7,987 
(1)
Manitowoc Healthcare Facility IIGreen Bay, WI 10/04/201919642010100%36,090 
(1)
Marinette Healthcare FacilityGreen Bay, WI 10/04/20192008100%4,178 
(1)
22

Table of Contents
Property NameMSA/µSADate AcquiredYear ConstructedYear Renovated% LeasedLeased Sq FtEncumbrances,
$ (in thousands)
New Bedford Healthcare FacilityProvidence-Warwick, RI-MA 10/04/201919421995100%70,657 
New Braunfels Healthcare FacilitySan Antonio-New Braunfels, TX 10/04/20192007100%27,971 
(1)
North Smithfield Healthcare FacilityProvidence-Warwick, RI-MA 10/04/201919652000100%92,944 
(1)
Oklahoma City Healthcare Facility IXOklahoma City, OK 10/04/20192007100%34,970 
(1)
Oshkosh Healthcare FacilityOshkosh-Neenah, WI 10/04/20192010100%8,717 
(1)
Palm Desert Healthcare FacilityRiverside-San Bernardino-Ontario, CA 10/04/20192005100%6,963 
Rancho Mirage Healthcare Facility IIRiverside-San Bernardino-Ontario, CA 10/04/201920082022100%7,432 
San Antonio Healthcare Facility IIISan Antonio-New Braunfels, TX 10/04/20192012100%50,000 
(1)
San Antonio Healthcare Facility IVSan Antonio-New Braunfels, TX 10/04/20191987100%113,136 
(1)
San Antonio Healthcare Facility VSan Antonio-New Braunfels, TX 10/04/2019201781%47,091 
(1)
Santa Rosa Beach Healthcare FacilityCrestview-Fort Walton Beach-Destin, FL 10/04/20192003100%5,000 
Savannah Healthcare FacilitySavannah, GA10/04/20192014100%48,184 
Sturgeon Bay Healthcare FacilityGreen Bay, WI 10/04/20192007100%3,100 
(1)
Victoria Healthcare FacilityVictoria, TX 10/04/20192013100%34,297 
(1)
Victoria Healthcare Facility IIVictoria, TX 10/04/20191998100%28,752 
(1)
Wilkes-Barre Healthcare FacilityScranton–Wilkes-Barre, PA10/04/20192012100%15,996 
(1)
Yucca Valley Healthcare FacilityRiverside-San Bernardino-Ontario, CA 10/04/20192009100%12,240 
Tucson Healthcare Facility IITucson, AZ12/26/20192021100%60,913 
(1)
Tucson Healthcare Facility IIITucson, AZ12/27/20192020100%20,000 
(1)
Grimes Healthcare FacilityDes Moines-West Des Moines, IA02/19/20202018100%14,669 
(1)
Tampa Healthcare FacilityTampa-St. Petersburg-Clearwater, FL09/08/20202015100%33,822 
(1)
Tucson Healthcare Facility IVTucson, AZ12/22/20202022100%44,692 
(1)
Greenwood Healthcare FacilityIndianapolis-Carmel-Greenwood, IN04/19/202120082018100%53,560 
(1)
Clive Healthcare Facility IIDes Moines-West Des Moines, IA12/08/20212008100%63,224 
(1)
Clive Healthcare Facility IIIDes Moines-West Des Moines, IA12/08/20212008100%33,974 
(1)
Clive Healthcare Facility IVDes Moines-West Des Moines, IA12/08/202120092018100%35,419 
(1)
Clive Undeveloped LandDes Moines-West Des Moines, IA12/08/2021—%— 
Clive Undeveloped Land IIDes Moines-West Des Moines, IA12/08/2021—%— 
Yukon Healthcare FacilityOklahoma City, OK03/10/20222020100%45,624 
(1)
Pleasant Hills Healthcare FacilityPittsburgh, PA05/12/20222015100%33,712 
(1)
Prosser Healthcare Facility IKennewick-Richland, WA05/20/20222020100%6,000 
(1)
Prosser Healthcare Facility IIKennewick-Richland, WA05/20/202220132019100%9,230 
(1)
Prosser Healthcare Facility IIIKennewick-Richland, WA05/20/20222013100%5,400 
(1)
Tampa Healthcare Facility IITampa-St. Petersburg-Clearwater, FL07/20/20222022100%87,649 
(1)
Escondido Healthcare FacilitySan Diego-Carlsbad, CA07/21/20222021100%56,800 
(1)
West Palm Beach Healthcare FacilityMiami-Fort Lauderdale-West Palm Beach, FL06/15/202319992007/2019100%25,150 
(1)
Burr Ridge Healthcare FacilityChicago-Naperville-Elgin, IL-IN09/27/20232010100%104,912 
5,085,257 
(1)Property is contributed to the pool of unencumbered properties of our credit facility. As of December 31, 2023, 111 commercial real estate properties were contributed to the pool of unencumbered properties under our credit facility and we had an outstanding principal balance of $525,000,000.
(2)Property is currently under renovation.
We believe the properties are adequately covered by insurance and are suitable for their respective intended purposes. Real estate assets, other than land, are depreciated on a straight-line basis over each asset's useful life. Tenant improvements are depreciated on a straight-line basis over the shorter of the respective lease term or expected useful life.
23

Table of Contents
Leases
As of December 31, 2023, the weighted average remaining lease term of our properties was 8.5 years. The properties generally are leased under net leases pursuant to which the tenant bears responsibility for substantially all property costs and expenses associated with ongoing maintenance and operation, including utilities, property taxes and insurance. The majority of our leases provide for fixed increases in rent. Generally, the property leases provide the tenant with one or more multi-year renewal options, subject to generally the same terms and conditions as the initial lease term.
Lease expirations of our real properties based on annualized contractual base rent as of December 31, 2023, for each of the next ten years ending December 31 and thereafter, are as follows:
Year of Lease
Expiration
Total Number
of Leases
Leased Sq Ft
Annualized Contractual
Base Rent
(in thousands) (1)
Percentage of
Annualized Contractual
Base Rent
202418 143,230 $4,432 2.7 %
202512 246,413 7,768 4.8 %
202613 202,884 5,977 3.7 %
2027277,229 7,107 4.4 %
202811 238,571 5,301 3.3 %
202919 520,887 11,239 7.0 %
203014 553,432 18,635 11.5 %
203112 497,414 20,412 12.6 %
2032175,658 7,188 4.5 %
203312 478,568 20,744 12.8 %
Thereafter32 1,750,971 52,642 32.7 %
158 5,085,257 $161,445 100.0 %
(1)Annualized contractual base rent is based on leases in effect as of December 31, 2023.
Item 3. Legal Proceedings.
We are not aware of any material pending legal proceedings to which we are a party or to which our properties are the subject.
Item 4. Mine Safety Disclosures.
Not applicable.
PART II
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Market Information
There is no established public trading market for our common stock. Therefore, a stockholder may not be able to sell our stock at a time or price acceptable to the stockholder, or at all. Unless and until our shares are listed on a national securities exchange, we do not expect that a public market for the shares will develop.
As of December 31, 2023, the offering price for the shares in the DRIP Offering was $7.48 per Class A share, $7.48 per Class I share and $7.48 per Class T share, which is equal to the Estimated Per Share NAV, as approved by the Board and effective on December 18, 2023.
We will continue to issue shares of Class A common stock, Class I common stock and Class T common stock under the current DRIP Offering until such time as we sell all of the shares registered for sale under the current DRIP Offering, unless we file a new registration statement with the SEC or the current DRIP Offering is terminated by the Board. We will issue such shares at the applicable Estimated Per Share NAV.
As of May 2022, all outstanding shares of Class T2 common stock (including associated shares of Class T2 DRIP common stock) were converted into shares of Class I common stock. Stockholders received a confirmation notice when their shares of Class T2 common stock were converted into shares of Class I common stock.
24

Table of Contents
Pursuant to the terms of our charter, certain restrictions are imposed on the ownership and transfer of shares.
To assist the FINRA members and their associated persons that participated in our public offerings of common stock, pursuant to FINRA Rule 5110 and NASD Conduct Rule 2340, we disclose in each annual report distributed to stockholders a per share estimated value of the shares, the method by which it was developed, and the date of the data used to develop the estimated value. In addition, we prepare annual statements of estimated share values to assist fiduciaries of retirement plans subject to the annual reporting requirements of ERISA in the preparation of their reports relating to an investment in our shares. For these purposes, the Estimated Per Share NAV of our common shares was $7.48 as of December 31, 2023. However, as set forth above, there is no public trading market for the shares at this time and stockholders may not receive $7.48 per share if a market did exist.
The Estimated Per Share NAV was approved by the Board, at the recommendation of the Audit Committee, on December 18, 2023, using a methodology that conformed to standard industry practice. In determining the Estimated Per Share NAV, the Board considered information and analyses, including valuation materials that were provided by Cushman & Wakefield of Pennsylvania, LLC, information provided by us and the recommendation of the Audit Committee. See our Current Report on Form 8-K filed with the SEC on December 19, 2023 for additional information regarding Cushman & Wakefield of Pennsylvania, LLC, and its valuation materials and the methodology used to determine the Estimated Per Share NAV.
Stockholder Information
As of February 29, 2024, we had 63,474 stockholders of record. The number of stockholders is based on the records of Computershare Trust Company, N.A., who serves as our registrar and transfer agent.
Distributions
We are taxed and qualify as a REIT for federal income tax purposes. As a REIT, we make distributions each taxable year equal to at least 90% of our REIT taxable income (computed without regard to the dividends paid deduction and excluding capital gains). One of our primary goals is to continue to pay monthly distributions to our stockholders.
Unregistered Sales of Equity Securities
There were no unregistered sales of equity securities during the quarter ended December 31, 2023.
Share Repurchase Program
Prior to the time that our shares are listed on a national securities exchange, if ever, our Amended and Restated Share Repurchase Program, or the SRP, as described below, may provide eligible stockholders with limited, interim liquidity by enabling them to sell shares back to us, subject to restrictions and applicable law. We are not obligated to repurchase shares under our SRP.
We currently only repurchase shares due to death and involuntary exigent circumstances in accordance with our SRP, subject in each case to the terms and limitations of the SRP, including, but not limited to, quarterly share limitations, an annual 5.0% share limitation, and DRIP funding limitations. Under our SRP, we may waive certain of the terms and requirements of the SRP in the event of the death of a stockholder who is a natural person, including shares held through an Individual Retirement Account, or IRA, or other retirement or profit-sharing plan, and certain trusts meeting the requirements of the SRP. We may also waive certain of the terms and requirements of the SRP in the event of an involuntary exigent circumstance, as determined by us or any of the executive officers thereof, in our or their sole discretion.
Holding Period. Generally, a stockholder must have beneficially held its Class A shares, Class I shares or Class T shares, as applicable, for at least one year prior to offering them for sale to us through our share repurchase program. A stockholder or a stockholder’s fiduciary, heir or beneficiary may present to us fewer than all of the shares owned for repurchase.
Distribution Reinvestment Plan. In the event that we repurchase all of one stockholder’s shares, any shares that the stockholder purchased pursuant to our DRIP, will be excluded from the one-year holding requirement. In the event that a stockholder requests a repurchase of its shares, and such stockholder is participating in the DRIP, the stockholder will be deemed to have notified us, at the time the stockholder submits the repurchase request, that the stockholder is terminating participation in the DRIP and has elected to receive future distributions in cash. This election for cash distributions will continue in effect even if less than all of the stockholder’s shares are accepted for repurchase unless the stockholder notifies us that the stockholder wishes to re-enroll to participate in the DRIP.
Death of a Stockholder. Subject to the conditions and limitations described below, we may waive certain of the terms and requirements of our share repurchase program in the event of the death of a stockholder who is a natural person, including shares held by such stockholder through an IRA or other retirement or profit-sharing plan, and certain trusts meeting the
25

Table of Contents
requirements detailed in this program. With regard to trusts, the right to request a repurchase upon death applies upon the death of the settlor of a trust that holds shares, if the trust becomes irrevocable upon the death of the settlor or settlor’s spouse, or the spouse of a settlor of a trust, if the trust became irrevocable upon the death of the settlor and the settlor’s spouse was the beneficiary of the trust, as applicable, after receiving written notice from the fiduciary appointed for the stockholder’s estate, the recipient of the shares through bequest or inheritance, or, in the case of a trust that becomes irrevocable upon the death of the settlor (or previously became irrevocable upon the death of the settlor’s spouse), the then-serving trustee of such trust, who shall be the sole person authorized to request the repurchase on behalf of the trust. We must receive the written repurchase request within 18 months after the death of the stockholder, the date on which a trust became irrevocable due to death, or the date of death of the settlor’s surviving spouse who was the beneficiary of a trust that became irrevocable due to the death of the settlor, as applicable, in order for the requesting party to rely on any of the special treatment described below that may be afforded in the event of death. Such written request must be accompanied by a certified copy of the official death certificate of the stockholder, settlor, and or settlor’s spouse, as applicable. In addition, written requests in connection with shares held in a trust must include an executed Certification of Trust for Repurchase form, pursuant to which the trustee must agree to indemnify and hold our company harmless from and against any liability arising from the repurchase. If spouses are joint registered holders of the shares, the request to repurchase the shares may be made only if both registered holders are deceased. If the stockholder is not a natural person, as in the case of a trust that does not become irrevocable upon the death of the settlor or the settlor’s spouse (as described above in this paragraph), a partnership, a corporation, a limited liability company, or other similar entity, the right of repurchase upon death does not apply.
Qualifying Disability. Subject to the conditions and limitations described within our SRP, we may waive certain of the terms and requirements of our SRP with respect to shares held by a stockholder, including shares held by such stockholder through an IRA or other retirement or profit-sharing plan, with a “Qualifying Disability” as defined in our SRP, after receiving written notice from such stockholder within 18 months from the date that the stockholder becomes subject to the Qualifying Disability; provided that the condition causing the Qualifying Disability was not pre-existing on the date that the stockholder became a stockholder.
Involuntary Exigent Circumstance. The Company or any of its executive officers may, in its or their sole discretion, waive certain of the terms and requirements of our SRP with respect to shares held by a stockholder who is a natural person and certifies in an executed Certification Regarding Exigent Circumstances for Repurchase form, that he or she: (a) has been diagnosed with a condition caused by injury, disease, or illness from which there is no reasonable medical probability of recovery and the stockholder’s life expectancy is less than twenty-four (24) months, as evidenced by a physician certification; and (b) is experiencing financial need, such that, if the repurchase request is not granted, the stockholder would be unable to meet the basic financial obligations to support himself/herself and such stockholder’s dependents, which is referred to as an “Involuntary Exigent Circumstance” in our SRP. Stockholders requesting repurchases due to Involuntary Exigent Circumstance are required to indemnify and hold the Company harmless from and against any liability arising from the repurchase.
Purchase Price. The purchase price for shares repurchased under our SRP will be 100% of the most recent estimated NAV per share of the Class A common stock, Class I common stock or Class T common stock, as applicable (in each case, as adjusted for any stock dividends, combinations, splits, recapitalizations and the like with respect to our common stock). The Board will adjust the estimated NAV per share of each our classes of common stock if we have made one or more special distributions to stockholders. The Board will determine, in its sole discretion, which distributions, if any, constitute a special distribution.
Timing of Share Repurchases. Repurchases of our shares are at our discretion and generally will be made quarterly upon written request to us by the last day of the applicable quarter. Valid repurchase requests will be honored approximately 30 days following the end of the applicable quarter, which we refer to as the “Repurchase Date.” Stockholders may withdraw their repurchase request at any time up to 15 days prior to the Repurchase Date. If a repurchase request is granted, we or our agent will send the repurchase amount to each stockholder or heir, beneficiary or estate of a stockholder on or about the Repurchase Date.
Repurchase Limitations. We will determine whether we have sufficient funds and/or shares available as soon as practicable after the end of each fiscal quarter, but in any event prior to the applicable Repurchase Date.
a. 5% Share Limitation. During any calendar year, we will not repurchase shares in excess of 5.0% of the number of shares of common stock outstanding on December 31st of the previous calendar year, or the 5% Share Limitation.
b. Quarterly Share Limitations. We limit the number of shares repurchased each quarter pursuant to our SRP as follows (subject to the DRIP Funding Limitation (as defined below)):
On the first quarter Repurchase Date, which generally will be on or about January 30 of the applicable year, we will not repurchase in excess of 1.25% of the number of shares outstanding on December 31st of the previous calendar year;
26

Table of Contents
On the second quarter Repurchase Date, which generally will be on or about April 30 of the applicable year, we will not repurchase in excess of 1.25% of the number of shares outstanding on December 31st of the previous calendar year;
On the third quarter Repurchase Date, which generally will be on or about July 30 of the applicable year, we will not repurchase in excess of 1.25% of the number of shares outstanding on December 31st of the previous calendar year; and
On the fourth quarter Repurchase Date, which generally will be on or about October 30 of the applicable year, we will not repurchase in excess of 1.25% of the number of shares outstanding on December 31st of the previous calendar year.
In the event we do not repurchase 1.25% of the number of shares outstanding on December 31st of the previous calendar year in any particular quarter, we will increase the limitation on the number of shares to be repurchased in the next quarter and continue to adjust the quarterly limitations as necessary in accordance with the 5% annual limitation.
c.    DRIP Funding Limitations. We intend to fund our SRP with proceeds we received during the prior year ended December 31 from the sale of shares pursuant to the DRIP. We will limit the amount of DRIP proceeds used to fund share repurchases in each quarter to 25% of the amount of DRIP proceeds received during the previous calendar year, or the DRIP Funding Limitation; provided, however, that if we do not reach the DRIP Funding Limitation in any particular quarter, we will apply the remaining DRIP proceeds to the next quarter Repurchase Date and continue to adjust the quarterly limitations as necessary in order to use all of the available DRIP proceeds for a calendar year, if needed. We cannot guarantee that DRIP proceeds will be sufficient to accommodate all requests made each quarter. The Board may, in its sole discretion, reserve other operating funds to fund the SRP, but is not required to reserve such funds.
As a result of the limitations described in (a) - (c) above, some or all of a stockholder’s shares may not be repurchased. Each quarter, we will process repurchase requests made in connection with the death of a stockholder, or, in our sole discretion, an Involuntary Exigent Circumstance. If we are unable to process all eligible repurchase requests within a quarter due to the limitations described above or in the event sufficient funds are not available, shares will be repurchased as follows: (i) first, pro rata as to repurchases upon the death of a stockholder; and (ii) second, pro rata as to repurchases to stockholders who demonstrate, in our sole discretion, an Involuntary Exigent Circumstance.
If we do not repurchase all of the shares for which repurchase requests were submitted in any quarter, all outstanding repurchase requests will automatically roll over to the subsequent quarter and priority will be given to the repurchase requests in the subsequent quarter as provided above. A stockholder or his or her estate, heir or beneficiary, as applicable, may withdraw a repurchase request in whole or in part at any time up to 15 days prior to the Repurchase Date.
Deadline for Presentment. A stockholder who wishes to have shares repurchased must mail or deliver to us a written request on a form provided by us and executed by the stockholder, its trustee or authorized agent, which we must receive by the last day of the quarter in which the stockholder is requesting a repurchase of his or her shares. The fiduciary of an estate, heir, beneficiary, or trustee of a trust that wishes to have shares repurchased following the death of a stockholder must mail or deliver to us a written request on a form provided by us, including evidence acceptable to us of the death of the stockholder, and executed by the fiduciary of the estate, the heir or beneficiary, or the trustee, as applicable, which we must receive by the last day of the quarter in which the fiduciary of the estate, heir, beneficiary, or trustee is requesting a repurchase of its shares.
No Encumbrances. All shares presented for repurchase must be owned by the stockholder(s) making the presentment, or the party presenting the shares must be authorized to do so by the owner(s) of the shares. Such shares must be fully transferable and not subject to any liens or encumbrances. Upon receipt of a request for repurchase, we may conduct a Uniform Commercial Code search to ensure that no liens are held against the shares. Any costs in conducting the Uniform Commercial Code search will be borne by us.
Account Minimum. In the event any stockholder fails to maintain a minimum balance of $2,000 of Class A shares, Class I shares, or Class T shares, we may repurchase all of the shares held by that stockholder at the NAV per share repurchase price in effect on the date we determine that the stockholder has failed to meet the minimum balance.
Termination, Amendment or Suspension of the Program. Our SRP will immediately terminate if our shares are listed on any national securities exchange. In addition, the Board may, in its sole discretion, suspend (in whole or in part) our SRP at any time and from time to time upon notice to our stockholders and may, in its sole discretion amend or terminate our SRP at any time upon 30 days’ prior notice to our stockholders for any reason it deems appropriate. Because we generally only repurchase shares on a quarterly basis, depending upon when during the quarter the Board makes this determination, it is possible that our stockholders would not have any additional opportunities to have their shares repurchased under the prior terms of the program, or at all, upon receipt of the notice. Because share repurchases will be funded with the net proceeds we receive from the sale of shares under our DRIP or other operating funds reserved by the Board in its sole discretion, the discontinuance or termination
27

Table of Contents
of the DRIP or the Board’s decision not to reserve other operating funds to fund our SRP would adversely affect our ability to repurchase shares under our SRP. We will notify our stockholders of such developments: (1) in a current report on Form 8-K, an annual report on Form 10-K or a quarterly report on Form 10-Q; or (2) by means of a separate mailing to our stockholders.
During the three months ended December 31, 2023, we fulfilled the following repurchase requests pursuant to our SRP:
PeriodTotal Number of
Shares Repurchased
Average
Price Paid per
Share
Total Number
of Shares Purchased
as Part of Publicly
Announced Plans
and Programs
Approximate Dollar Value
of Shares Available
 that may yet
be Repurchased under the
Program
October 1, 2023 - October 31, 2023368,926 $8.13 — $— 
November 1, 2023 - November 30, 2023— $— — $— 
December 1, 2023 - December 31, 2023— $— — $— 
Total368,926 — 
During the three months ended December 31, 2023, we repurchased approximately $2,998,000 of Class A shares, Class I shares and Class T shares of common stock.
Item 6. [Reserved]
Information pertaining to Item 6 is not presented in accordance with amendments to Item 301 of Regulation S-K.
28

Table of Contents
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the notes thereto and the other financial information appearing elsewhere in this Annual Report on Form 10-K. The discussion contains forward looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of various factors, including those discussed below and elsewhere in this report, particularly under “Risk Factors” and “Forward-Looking Statements.” All forward-looking statements in this document are based on information available to us as of the date hereof, and we assume no obligation to update any such forward-looking statements.
This section of the Annual Report on Form 10-K generally discusses 2023 and 2022 items and year-to-year comparisons between 2023 and 2022. A discussion of the changes in our financial condition and results of operations for the years ended December 31, 2022, and 2021 may be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of our Annual Report on Form 10-K for the fiscal years ended December 31, 2022 and December 31, 2021.
Overview
We invest in high quality properties leased to tenants capitalizing on critical and structural economic growth drivers. We are primarily focused on investing in healthcare assets across the continuum of care, which we believe typically generate predictable, durable and growing income streams. We may also make other real estate-related investments, which may include equity or debt interests in other real estate entities.
As of December 31, 2023, we owned 131 real estate properties and two undeveloped land parcels.
We raised the equity capital for our real estate investments through our Offerings from May 2014 through November 2018, and we have offered shares pursuant to the DRIP Offerings since November 2017.
Critical Accounting Estimates
The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect reported amounts of assets, liabilities, revenues and expenses. Changes in these estimates and assumptions could have a significant effect on the financial statements. From time to time, we evaluate our estimates based on historical experience and various assumptions that we believe are reasonable under the circumstances. Although our actual results historically have not deviated materially from those determined using estimates, our results of operations or financial condition could differ materially from these estimates under different assumptions or conditions.
We consider our critical accounting estimates to be those used in the determination of the reported amounts and disclosure related to the impairment of long-lived assets.
We review our real estate assets on an asset group basis for impairment. Typically, an individual property constitutes an asset group. We identify an asset group based on the lowest level of identifiable cash flows. In the impairment analysis we must determine whether there are indicators of impairment. For operating properties, these indicators could include a tenant being delinquent or not paying rent, a reduction in our estimated hold period, a significant decline in a property’s leasing percentage, a current period operating loss or negative cash flows combined with a history of losses at the property, a significant decline in lease rates for that property or others in the property’s market, a significant change in the market value of the property, or an adverse change in the financial condition of significant tenants.
If we determine that an asset has indicators of impairment, we then determine whether the undiscounted cash flows associated with the asset group exceed the carrying amount of the asset group. In calculating the undiscounted net cash flows of an asset group, we use considerable judgment to estimate several inputs. We estimate future rental rates, future capital expenditures, future operating expenses, and market capitalization rates for residual values, among other things. In addition, if there are alternative strategies for the future use of the asset, we assess the probability of each alternative strategy and perform a probability-weighted undiscounted cash flow analysis to assess the recoverability of the asset group. If the carrying value of the asset group exceeds the estimated undiscounted cash flows, an impairment loss is recognized equal to the excess of carrying value over the estimated fair value of the asset group.
In determining the fair value of an asset group, we exercise considerable judgment on several factors. We may determine fair value by using a direct capitalization method, a discounted cash flow method or by utilizing comparable sales information. The direct capitalization method is based on a capitalization rate applied to the underlying asset group's most recent stabilized trailing twelve-month net operating income at the measurement date. The discounted cash flow method is based on estimated future cash flow projections utilizing discount rates, terminal capitalization rates, and planned capital expenditures. We use
29

Table of Contents
judgment to determine an appropriate discount rate to apply to the cash flows in the discounted cash flow calculation. We also use judgment in analyzing comparable market information because no two real estate assets are identical in location and price.
The estimates and judgments used in the impairment process are highly subjective and susceptible to frequent change. Significant increases or decreases in any of these inputs, particularly with regard to cash flow projections and discount and capitalization rates, would result in a significantly lower or higher fair value measurement of the real estate assets being assessed. Additionally, changes in economic and operating conditions, including changes in the financial condition of our tenants, and changes to our intent and ability to hold the related asset, that occur after our impairment assessment could impact the assumptions used in that assessment and could result in future charges to earnings if assumptions regarding those investments differ from actual results.
Real Estate Acquisitions and Dispositions in 2023
We purchased two healthcare properties, comprising approximately 130,000 rentable square feet for an aggregate purchase price of approximately $69,822,000.
We sold three healthcare properties for an aggregate sale price of $271,107,000 and generated net proceeds of $270,306,000.
Factors That May Influence Results of Operations
We are not aware at this time of any material trends or uncertainties, other than national economic conditions and those discussed below and in Part I. Item 1A. "Risk Factors" of this Annual Report on Form 10-K, affecting our real estate properties, that may reasonably be expected to have a material impact, favorable or unfavorable, on revenues or income, management and operation of our properties.
Rental Revenue
The amount of rental revenue generated by our properties depends principally on our ability to maintain the occupancy rates of leased space and to lease available space at existing rental rates. Negative trends in one or more of these factors could adversely affect our rental revenue in future periods. We continually monitor our tenants' ability to meet their lease obligations to pay us rent to determine if any adjustments should be reflected currently. As of December 31, 2023, our real estate properties were 99.4% leased.
GenesisCare Bankruptcy Filing
As disclosed in the Current Report on Form 8-K that the Company filed with the SEC on June 5, 2023, GenesisCare, sponsor and owner of the tenant in 17 of our real estate properties, announced that it filed for Chapter 11 bankruptcy protection under the United States Bankruptcy Code. GenesisCare sought U.S. bankruptcy court approval to reject certain unexpired real property leases. GenesisCare's lease obligations with us were not included in any motions. GenesisCare continues to make its lease payments due to us in accordance with their contractual terms, although we are in ongoing negotiations with GenesisCare regarding certain adjustments to its lease. Bankruptcy proceedings are subject to uncertainty and there can be no assurance how the bankruptcy court's or other parties' actions or decisions may impact GenesisCare. Due to GenesisCare filing for bankruptcy and its subsequent emergence from bankruptcy on February 16, 2024, we determined the collectability of amounts owed under the contractual terms of GenesisCare's lease were no longer reasonably assured. As a result, we ceased recognizing rent on a straight-line basis and have only recorded rent for GenesisCare to the extent we have received cash. In addition, during the year ended December 31, 2023, we wrote off $1,630,000 of straight-line rent receivables related to GenesisCare, as a reduction in rental revenue, because the amounts were determined to be uncollectible.
Results of Operations
Our results of operations are influenced by the timing of acquisitions and the performance of our real estate properties. The following table shows the property statistics of our real estate properties as of December 31, 2023 and 2022:
 December 31,
 20232022
Number of real estate properties (1)
131 132 
Leased square feet5,085,000 5,508,000 
Weighted average percentage of rentable square feet leased99.4 %99.5 %
(1)As of December 31, 2023, we owned 131 real estate properties and two undeveloped land parcels. As of December 31, 2022, we owned 132 real estate properties and two undeveloped land parcels.
30

Table of Contents
The following table summarizes our real estate activity for the years ended December 31, 2023 and 2022:
 Year Ended
December 31,
 20232022
Real estate properties acquired
Real estate properties disposed— 
(1)
Aggregate purchase price of real estate properties acquired (2)
$69,822,000 $157,194,000 
Net book value of real estate properties disposed$270,279,000 $— 
(1)
Leased square feet of real estate property additions130,000 284,000 
Leased square feet of real estate property dispositions551,000 — 
(1)During the year ended December 31, 2022, we disposed of one land parcel that formerly contained a property.
(2)Includes capitalized acquisition costs associated with transactions determined to be asset acquisitions.
This section describes and compares our results of operations for the years ended December 31, 2023 and 2022. We generate substantially all of our revenue from property operations. In order to evaluate our overall portfolio, management analyzes the results of our same store properties. We define "same store properties" as properties that were owned and operated for the entirety of both calendar periods being compared and exclude properties under development, re-development, or classified as held for sale.
By evaluating the results of our same store properties, management is able to monitor the operations of our existing properties for comparable periods to measure the performance of our current portfolio and readily observe the expected effects of our new acquisitions and dispositions on net income.
Year Ended December 31, 2023 Compared to Year Ended December 31, 2022
The following table allocates total rental revenue for the year ended December 31, 2023 compared to the comparable period in 2022 (amounts in thousands).
Year Ended
December 31,
20232022$ Change% Change
Same store rental revenue$143,381 $145,167 $(1,786)(1.2)%
Same store tenant reimbursements10,608 10,121 487 4.8 %
Non-same store rental revenue32,942 23,877 9,065 38.0 %
Non-same store tenant reimbursements2,128 817 1,311 160.5 %
Other operating income50.0 %
Total rental revenue$189,065 $179,986 $9,079 5.0 %
Same store rental revenue decreased primarily due to a $1,861,000 decrease related to tenants who ceased paying all or a portion of their rent, an $834,000 increase in the write-off of straight-line rent receivables related to prior periods due to tenant uncertainty and an impairment of above-market lease intangible assets of $260,000, partially offset by a $913,000 increase in annual base rent escalations for leases indexed to CPI and a $256,000 increase from new and renewal leases.
Same store tenant reimbursements increased $487,000 primarily due to higher operating costs in the current year which are generally passed along to our tenants.
Non-same store rental revenue increased primarily due to lease termination income of $5,185,000 and a $6,406,000 increase attributable to properties acquired and properties placed in service since January 1, 2022, partially offset by a $2,427,000 decrease due to property dispositions and a $99,000 decrease due to deferment of rent on a property under renovation.
Non-same store tenant reimbursements increased $1,311,000 primarily due to properties acquired and placed in service since January 1, 2022.
There were no significant changes in other operating income.
31

Table of Contents
Changes in our expenses are summarized in the following table (amounts in thousands):
Year Ended
December 31,
20232022$ Change% Change
Same store rental expenses$16,796 $16,007 $789 4.9 %
Non-same store rental expenses3,400 1,943 1,457 75.0 %
General and administrative expenses23,896 22,079 1,817 8.2 %
Depreciation and amortization74,293 77,199 (2,906)(3.8)%
Impairment losses24,252 47,424 (23,172)(48.9)%
Total operating expenses$142,637 $164,652 $(22,015)(13.4)%
Gain on real estate dispositions$22 $460 $(438)(95.2)%
Same store rental expenses, certain of which are subject to reimbursement by our tenants, increased $789,000 primarily due to higher operating costs in the current year.
Non-same store rental expenses, certain of which are subject to reimbursement by our tenants, increased primarily due to a $1,666,000 increase from properties acquired and properties placed in service since January 1, 2022, partially offset by a $209,000 decrease due to property dispositions.
General and administrative expenses increased primarily due to a $2,188,000 increase in stock-based compensation due to equity awards granted in 2023, and $512,000 additional separation pay primarily related to our former chief accounting officer and former chief administrative officer, partially offset by a $84,000 decrease in accelerated stock-based compensation related to former officers and directors, a decrease of $449,000 as a result of a reduction in personnel, and a $350,000 decrease in reporting costs.
Depreciation and amortization decreased primarily due to a $1,392,000 decrease from property dispositions, a $771,000 decrease attributable to fully amortized in-place leases and tenant improvements, a $1,038,000 decrease related to properties impaired and a $3,215,000 decrease in impairments of an in-place lease intangible assets, partially offset by a $3,330,000 increase attributable to properties acquired and properties placed in service since January 1, 2022, and a $180,000 increase due to capital expenditures placed in service.
Impairment losses were recorded in the aggregate amount of $24,252,000 during the year ended December 31, 2023, as a result of property sales and tenant related triggering events that occurred at certain properties. Impairment losses were recorded in the aggregate amount of $47,424,000 during the year ended December 31, 2022, as a result of tenant related triggering events that occurred at certain properties.
Gains on real estate dispositions were $22,000 and $460,000 during the years ended December 31, 2023 and 2022, respectively.
Changes in interest expense and interest and other income are summarized in the following table (amounts in thousands):
Year Ended
December 31,
20232022$ Change% Change
Interest expense$23,110 $24,077 $(967)(4.0)%
Interest and other income(702)(305)(397)130.2 %
Interest expense decreased primarily due to $3,367,000 in loss on extinguishment of debt and $1,400,000 in interest rate swap amortization recognized during the year ended December 31, 2022, partially offset by an increase of $3,054,000 related to changes in the weighted average interest rate on our credit facility that was subject to variable rates during the year and an increase of $856,000 due to an increase in the weighted average outstanding principal balance on our credit facility of $32,452,000.
Interest and other income increased primarily due to a $457,000 increase in dividend income from investments in money market funds, a $118,000 increase in interest income from cash deposits, and a $105,000 increase in interest income on a note receivable, partially offset by a decrease of $283,000 in settlement income from disposed properties.
Liquidity and Capital Resources
Our principal uses of funds are for acquisitions of real estate and real estate-related investments, capital expenditures, operating expenses, distributions to, and share repurchases from, stockholders, and principal and interest payments on current
32

Table of Contents
and future indebtedness. While interest rates on variable rate debt have increased and may continue to increase, we believe our exposure is limited at this time due to our hedging strategy, which has effectively fixed 100% of our outstanding debt as of December 31, 2023, allowing us to reasonably project our liquidity needs. Generally, cash for these items is generated from operations of our current and future investments. Our sources of funds are primarily operating cash flows, funds equal to amounts reinvested in the DRIP, our credit facility and other potential borrowings.
When we acquire a property, we prepare a capital plan that contemplates the estimated capital needs of that investment. In addition to operating expenses, capital needs may also include, for example, costs of refurbishment, tenant improvements or other major capital expenditures. The capital plan also sets forth the anticipated sources of the necessary capital, which may include a line of credit, operating cash generated by the investment, additional equity investments from us, and when necessary, capital reserves. The capital plan for each investment will be adjusted through ongoing, regular reviews of our portfolio or, as necessary, to respond to unanticipated additional capital needs.
Short-term Liquidity and Capital Resources
For at least the next twelve months, we expect our principal demands for funds will be for operating expenses, including our general and administrative expenses, as well as the acquisition of real estate and real estate-related investments and funding of capital improvements and tenant improvements, distributions to and stock repurchases from stockholders, and interest payments on our credit facility. We expect to meet our short-term liquidity requirements through net cash flows provided by operations, funds equal to amounts reinvested in the DRIP and borrowings on our credit facility and potential other borrowings.
We believe we will have sufficient liquidity available to meet our obligations in a timely manner, under both normal and stressed conditions, for the next twelve months.
Long-term Liquidity and Capital Resources
Beyond the next twelve months, we expect our principal demands for funds will be for costs to acquire additional real estate properties, interest and principal payments on our credit facility, long-term capital investment demands for our real estate properties and our distributions necessary to maintain our REIT status.
We currently expect to meet our long-term liquidity requirements through proceeds from cash flows from operations and borrowings on our credit facility and potential other borrowings.
We expect to pay distributions to our stockholders from cash flows from operations; however, we have used, and may continue to use, other sources to fund distributions, as necessary, such as funds equal to amounts reinvested in the DRIP. To the extent cash flows from operations are lower due to lower-than-expected returns on the properties held or the disposition of properties, distributions paid to stockholders may be lower. We currently expect that substantially all net cash flows from our operations will be used to fund acquisitions, certain capital expenditures identified at acquisition, ongoing capital expenditures, interest and principal payments on outstanding debt and distributions to our stockholders.
Material Cash Requirements
As of December 31, 2023, we had approximately $202,019,000 in cash and cash equivalents. In addition to the cash we need to conduct our normal business operations, we expect to require approximately $19,944,000 in cash over the next twelve months, of which $17,198,000 is related to estimated interest payments on our outstanding debt (calculated based on our effective interest rates as of December 31, 2023) and $2,746,000 is related to our various obligations as lessee. We cannot provide assurances, however, that actual expenditures will not exceed these estimates. The 2024 Term Loan (as defined below) has a maturity date of December 31, 2024, and, at our election, may be extended for a period of six-months on no more than two occasions, subject to the satisfaction of certain conditions, including the payment of an extension fee. We currently meet these conditions and therefore may exercise our option to extend the maturity date if we so choose.
As of December 31, 2023, we had material obligations beyond 12 months (or that we will meet the extension criteria on the maturity date) in the amount of approximately $676,064,000, inclusive of $560,444,000 related to principal and estimated interest payments on our outstanding debt (calculated based on our effective interest rates as of December 31, 2023) and $115,620,000 related to our various obligations as lessee.
One of our principal liquidity needs is the payment of principal and interest on outstanding indebtedness. As of December 31, 2023, we had $525,000,000 of principal outstanding under our Unsecured Credit Facility (as defined below). We are required by the terms of certain loan documents to meet certain covenants, such as financial ratios and reporting requirements. As of December 31, 2023, we were in compliance with all such covenants and requirements on our Unsecured Credit Facility.
As of December 31, 2023, the aggregate notional amount under our derivative instruments was $525,000,000. We have agreements with each derivative counterparty that contain cross-default provisions; if we default on our indebtedness, then we could also be declared in default on our derivative obligations, resulting in an acceleration of payment of any net amounts due under our derivative contracts. As of December 31, 2023, we were in compliance with all such cross-default provisions.
33

Table of Contents
Debt Service Requirements
Credit Facility
As of December 31, 2023, the maximum commitments available under our senior unsecured revolving line of credit with Truist Bank, as Administrative Agent for the lenders, or the Revolving Credit Agreement, were $500,000,000, which may be increased, subject to lender approval, through incremental term loans and/or revolving loan commitments in an aggregate amount not to exceed $1,000,000,000. The maturity date for the Revolving Credit Agreement is February 15, 2026, which, at our election, may be extended for a period of six-months on no more than two occasions, subject to certain conditions, including the payment of an extension fee. As of December 31, 2023, the Revolving Credit Agreement had no outstanding principal balance.
As of December 31, 2023, the maximum commitments available under our senior unsecured term loan with Truist Bank, as Administrative Agent for the lenders, or the 2024 Term Loan Agreement, were $250,000,000, which may be increased, subject to lender approval, to an aggregate amount not to exceed $550,000,000. The 2024 Term Loan Agreement has a maturity date of December 31, 2024, and, at our election, may be extended for a period of six-months on no more than two occasions, subject to the satisfaction of certain conditions (which we currently meet), including the payment of an extension fee. As of December 31, 2023, the 2024 Term Loan Agreement had an aggregate outstanding principal balance of $250,000,000.
As of December 31, 2023, the maximum commitments available under our senior unsecured term loan with Truist Bank, as Administrative Agent for the lenders, or the 2028 Term Loan Agreement, were $275,000,000, which may be increased, subject to lender approval, to an aggregate amount not to exceed $500,000,000 and has a maturity date of January 31, 2028. The 2028 Term Loan Agreement is pari passu with our Revolving Credit Agreement and 2024 Term Loan Agreement. As of December 31, 2023, the 2028 Term Loan Agreement had an aggregate outstanding principal balance of $275,000,000.
We refer to the Revolving Credit Agreement, the 2024 Term Loan Agreement and the 2028 Term Loan Agreement, collectively, as the “Unsecured Credit Facility,” which has aggregate commitments available of $1,025,000,000, as of December 31, 2023. Generally, the proceeds of loans made under our Unsecured Credit Facility may be used for acquisition of real estate investments, funding of tenant improvements and leasing commissions with respect to real estate, repayment of indebtedness, funding of capital expenditures with respect to real estate, and general corporate and working capital purposes.
As of December 31, 2023, we had a total pool availability under our Unsecured Credit Facility of $1,025,000,000 and an aggregate outstanding principal balance of $525,000,000; therefore, $500,000,000 was available to be drawn under our Unsecured Credit Facility. We were in compliance with all the financial covenant requirements as of December 31, 2023.
Cash Flows
Year Ended December 31, 2023 Compared to Year Ended December 31, 2022
Year Ended
December 31,
(in thousands)20232022Change
Net cash provided by operating activities$128,924 $121,675 $7,249 
Net cash provided by (used in) investing activities$197,307 $(142,812)$340,119 
Net cash (used in) provided by financing activities$(137,129)$1,340 $(138,469)
Operating Activities
Net cash provided by operating activities increased primarily due to an increase in cash collected for rent resulting from acquiring and placing properties in service, annual rent increases, new leasing and renewal activity and the receipt of lease termination income, partially offset by a decrease related to property dispositions and tenants who ceased paying all or a portion of their rent and an increase in interest paid on our credit facility.
Investing Activities
Significant investing activities included:
Investment of $69,822,000 to purchase two properties during the year ended December 31, 2023, compared to an investment of $157,194,000 to purchase seven properties during the year ended December 31, 2022.
Sale of three properties for net proceeds of $270,306,000 during the year ended December 31, 2023, compared to receiving $22,822,000 from the sale of a land parcel that formerly contained a property during the year ended December 31, 2022.
34

Table of Contents
Incurred capital expenditures, primarily for tenant improvements, of $3,177,000 during the year ended December 31, 2023, compared to incurring $8,440,000 during the year ended December 31, 2022.
Financing Activities
Significant financing activities included:
Payment of $66,515,000 in cash distributions to common stockholders during the year ended December 31, 2023, compared to $65,310,000 during the year ended December 31, 2022.
Repurchase of $12,374,000 of common stock under our share repurchase program during the year ended December 31, 2023, compared to $9,217,000 during the year ended December 31, 2022.
The following Unsecured Credit Facility related activity during the year ended December 31, 2023:
Repayment of $58,000,000 on the Revolving Credit Agreement with cash flows from operations and proceeds from a disposition;
Repayment of $50,000,000 on the 2024 Term Loan Agreement with proceeds from dispositions, the collection of a note receivable related to a disposition and cash flows from operations; and
Draw of $50,000,000 on the Revolving Credit Agreement to fund an acquisition.
The following Unsecured Credit Facility related activity during the year ended December 31, 2022:
Draw of $70,000,000 on the Revolving Credit Agreement to fund acquisitions;
Draw of $70,000,000 on the 2028 Term Loan Agreement to fund acquisitions;
Repayment of $57,000,000 on the Revolving Credit Agreement with proceeds from dispositions and cash flows from operations;
Replacement of $500,000,000 from our prior unsecured credit facility with borrowings from our new Revolving Credit Agreement and 2024 Term Loan Agreement;
Draw of $205,000,000 on the 2028 Term Loan Agreement at closing to pay down the $205,000,000 outstanding balance on the Revolving Credit Agreement; and
Payment of $6,937,000 in deferred financing costs as a result of entering into the Revolving Credit Agreement, 2024 Term Loan Agreement and 2028 Term Loan Agreement during the year ended December 31, 2022.
Distributions to Stockholders
We have paid, and may continue to pay, distributions from sources other than from our cash flows from operations. For the year ended December 31, 2023, our cash flows provided by operations of approximately $128,924,000 covered 100% of our ordinary distributions paid (total ordinary distributions were approximately $91,266,000, of which $66,515,000 was cash and $24,751,000 was reinvested in shares of our common stock pursuant to the DRIP) during such period. For the year ended December 31, 2022, our cash flows provided by operations of approximately $121,675,000 covered 100% of our ordinary distributions paid (total ordinary distributions were approximately $90,144,000, of which $65,310,000 was cash and $24,834,000 was reinvested in shares of our common stock pursuant to the DRIP) during such period.
We do not currently have any limits on the sources of funding distribution payments to our stockholders. We may pay distributions from any source, such as the sale of assets, the sale of additional securities, and offering proceeds and we do not currently have any limits on the amounts we may pay from such sources. See “Risk Factors – General Risk Factors – Distributions paid from sources other than our cash flows from operations, including from the proceeds of our Offerings, will result in us having fewer funds available for the acquisition of properties and real estate-related investments, which may adversely affect our ability to fund future distributions with cash flows from operations and may adversely affect a stockholder’s overall return” in Part I, Item 1A of this Annual Report on Form 10-K for a discussion of risks related to funding distribution payments from various sources.
For federal income tax purposes, distributions to common stockholders are characterized as ordinary dividends, capital gain distributions, or nontaxable distributions. To the extent that we make a distribution in excess of our current or accumulated earnings and profits, such excess will be a nontaxable return of capital, reducing the tax basis in each U.S. stockholder’s shares. Further, the amount of distributions in excess of a U.S. stockholder’s tax basis in such shares will be taxable as a realized gain.
35

Table of Contents
The following table shows the sources of distributions paid during the years ended December 31, 2023 and 2022 (amounts in thousands):
Year Ended December 31,
Character of Distributions (1):
20232022
Ordinary dividends61.41 %40.94 %
Capital gain distributions— %— %
Nontaxable distributions38.59 %59.06 %
Total100.00 %100.00 %
(1)Attributable to Class A shares, Class I shares, Class T shares of common stock for the year ended December 31, 2023. Attributable to Class A shares, Class I shares, Class T shares, and Class T2 shares of common stock for the years ended December 31, 2022 and 2021.
The amount of distributions payable to our stockholders is determined by the Board and is dependent on a number of factors, including our funds available for distribution, financial condition, lenders' restrictions and limitations, capital expenditure requirements, corporate law restrictions and the annual distribution requirements needed to maintain our status as a REIT under the Internal Revenue Code of 1986, as amended. The Board must authorize each distribution and may, in the future, authorize lower amounts of distributions or not authorize additional distributions and, therefore, distribution payments are not guaranteed.
The following table shows the sources of distributions paid during the years ended December 31, 2023 and 2022 (amounts in thousands):
Year Ended December 31,
20232022
Distributions paid in cash - common stockholders$66,515 $65,310 

Distributions reinvested (shares issued)24,751 24,834 
Total distributions$91,266 $90,144 
Source of distributions:
Cash flows provided by operations
$66,515 73 %
(1)
$65,310 72 %
(1)
Offering proceeds from issuance of common stock pursuant to the DRIP
24,751 27 %
(1)
24,834 28 %
(1)
Total sources$91,266 100 %$90,144 100 %
(1)Percentages were calculated by dividing the respective source amount by the total sources of distributions.
Total distributions declared but not paid on Class A shares, Class I shares and Class T shares as of December 31, 2023, were approximately $7,782,000 for common stockholders. These distributions were paid on January 8, 2024.
Share Repurchase Program
Our SRP allows for repurchases of shares of our common stock when certain criteria are met. Under the SRP, we currently only repurchase shares due to death or involuntary exigent circumstances, subject in each case to the terms and limitations of the SRP, including, but not limited to, quarterly share limitations, an annual 5.0% share limitation and DRIP funding limitations. See Part II, Item 5. "Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities" for more information on the SRP.
During the year ended December 31, 2023, we repurchased 1,513,997 Class A shares, Class I shares and Class T shares of common stock (1,182,006 Class A shares, 105,660 Class I shares and 226,331 Class T shares), for an aggregate purchase price of approximately $12,374,000 (an average of $8.17 per share). During the year ended December 31, 2022, we repurchased 1,123,183 Class A shares, Class I shares and Class T shares of common stock (981,772 Class A shares, 31,666 Class I shares and 109,745 Class T shares), for an aggregate purchase price of approximately $9,217,000 (an average of $8.21 per share).
Commitments and Contingencies
For a discussion of our commitments and contingencies, see Note 17—"Commitments and Contingencies" to the consolidated financial statements that are a part of this Annual Report on Form 10-K.
36

Table of Contents
Non-GAAP Financial Measures
In the real estate industry, analysts and investors employ certain non-GAAP supplemental financial measures in order to facilitate meaningful comparisons between periods and among peer companies. We believe that these measures are useful to investors to consider because they may assist them to better understand and measure the performance of our business over time and against similar companies. We use the following non-GAAP financial measures: Funds From Operations, or FFO, Core Funds From Operations, or Core FFO, and Adjusted Funds From Operations, or AFFO.
Net Income (Loss) and FFO, Core FFO and AFFO
A description of FFO, Core FFO, and AFFO and reconciliations of these non-GAAP measures to net income (loss), the most directly comparable GAAP measure, are provided below.
The National Association of Real Estate Investment Trusts, or NAREIT, an industry trade group, has promulgated the FFO measure, which we believe is an appropriate additional measure to reflect the operating performance of a REIT. The use of FFO is recommended by the REIT industry as a supplemental performance measure. FFO is not equivalent to our net income as determined under GAAP.
We define FFO, consistent with NAREIT’s definition, as net income (loss) (calculated in accordance with GAAP), excluding gains (or losses) from sales of real estate assets and impairments of real estate assets, plus depreciation and amortization of real estate assets, and after adjustments for unconsolidated partnerships and joint ventures. Adjustments for unconsolidated partnerships and joint ventures will be calculated to reflect FFO on the same basis. To date, we do not have any investments in unconsolidated partnerships or joint ventures.
We, along with many of our peers in the real estate industry, consider FFO to be an appropriate supplemental measure of a REIT’s operating performance, because it is based on a net income (loss) analysis of real estate portfolio performance that excludes non-cash items such as real estate depreciation and amortization and real estate impairments. We believe FFO provides a useful understanding of our performance to the investors and to our management, and when compared to year over year, FFO reflects the impact on our operations from trends in occupancy.
We calculate Core FFO by adjusting FFO to remove the effect of items that are not expected to impact our operating performance on an ongoing basis and consider it to be a useful supplemental measure because it provides investors with additional information to understand our sustainable performance. These include severance, write-off of straight-line rent receivables related to prior periods, accelerated stock-based compensation, amortization of above- and below-market lease intangibles (including ground leases) and loss on extinguishment of debt.
We calculate AFFO by further adjusting Core FFO for the following items: deferred rent, current period straight-line rent adjustments, amortization of deferred financing costs and stock-based compensation.
Presentation of this information is intended to assist management and investors in comparing the operating performance of different REITs, although it should be noted that not all REITs calculate FFO, Core FFO and AFFO the same way, so comparisons with other REITs may not be meaningful. Furthermore, FFO, Core FFO and AFFO are not necessarily indicative of cash flows available to fund cash needs and should not be considered as an alternative to net income (loss) as an indication of our performance or as an indication of our liquidity, including our ability to make distributions to our stockholders. FFO, Core FFO and AFFO may be useful in assisting management and investors in assessing the sustainability of operating performance in future operating periods. All of our non-GAAP financial measures should be reviewed in conjunction with other measurements as an indication of our performance. The method used to evaluate the value and performance of real estate under GAAP should be considered as a more relevant measure of operating performance and considered more prominent than the non-GAAP financial measures presented here.
37

Table of Contents
Reconciliation of Net Income (Loss) to FFO, Core FFO and AFFO
The following table presents a reconciliation of net income (loss) attributable to common stockholders, which is the most directly comparable GAAP financial measure, to FFO, Core FFO and AFFO for the years ended December 31, 2023 and 2022 (amounts in thousands):
Year Ended
December 31,
20232022
Net income (loss) attributable to common stockholders$24,042 $(7,978)
Adjustments:
Depreciation and amortization of real estate assets
74,202 77,099 
Gain on real estate dispositions(22)(460)
Impairment losses24,252 47,424 
FFO $122,474 $116,085 
Adjustments:
Severance 1,401 889 
Write-off of straight-line rent receivables related to prior periods3,268 2,434 
Accelerated stock-based compensation318 402 
Amortization of above (below) market lease intangibles, including ground leases1,386 1,044 
Loss on extinguishment of debt— 3,367 
Core FFO $128,847 $124,221 
Adjustments:
Deferred rent1,644 1,535 
Straight-line rent adjustments(5,465)(9,695)
Amortization of deferred financing costs1,665 1,679 
Stock-based compensation5,966 3,778 
AFFO $132,657 $121,518 
Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
Market risk includes risks that arise from changes in interest rates, foreign currency exchange rates, commodity prices, equity prices and other market changes that affect market sensitive instruments. In pursuing our business plan, the primary market risk to which we are exposed is interest rate risk.
We have obtained variable rate debt financing and we are exposed to such changes in the one-month Term SOFR. Loans under the Unsecured Credit Facility may be made as Base Rate Loans or SOFR Loans, at our election, and all of our interest rate swap agreements are indexed to SOFR. Our objectives in managing interest rate risk are to limit the impact of interest rate fluctuations on operations and cash flows, and to lower overall borrowing costs. To achieve these objectives, we will borrow primarily at interest rates with the lowest margins available and, in some cases, with the ability to convert variable interest rates to fixed rates.
As of December 31, 2023, our total principal debt outstanding of $525,000,000 was fixed through 11 interest rate swap agreements, which mature on various dates from December 2024 to January 2028. As of December 31, 2023, the interest rate swap agreements had an aggregate notional amount of $525,000,000 and an aggregate settlement asset value of $18,182,000. The settlement value of these interest rate swap agreements is dependent upon existing market interest rates and swap spreads. As of December 31, 2023, an increase of 50 basis points in the market rates of interest would have resulted in an increase to the settlement asset value of these interest rate swaps to a value of $24,111,000. These interest rate swap agreements were designated as cash flow hedging instruments.
As of December 31, 2023, the weighted average interest rate on our total debt outstanding was 3.3%. We have entered, and may continue to enter, into additional derivative financial instruments, such as interest rate swaps, in order to mitigate our interest rate risk on a given variable rate financial instrument. To the extent we do, we are exposed to credit risk and market risk. Credit risk is the failure of the counterparty to perform under the terms of the derivative contract. When the fair value of a derivative contract is positive, the counterparty owes us, which creates credit risk for us. When the fair value of a derivative contract is negative, we owe the counterparty and, therefore, it does not possess credit risk. Market risk is the adverse effect on the value of a financial instrument that results from a change in interest rates. We manage the market risk associated with
38

Table of Contents
interest rate contracts by establishing and monitoring parameters that limit the types and degree of market risk that may be undertaken. We have not entered, and do not intend to enter, into derivative or interest rate swap transactions for speculative purposes. We may also enter into rate-lock arrangements to lock interest rates on future borrowings.
In addition to changes in interest rates, the value of our future investments will be subject to fluctuations based on changes in local and regional economic conditions and changes in the creditworthiness of tenants, which may affect our ability to refinance our debt, if necessary.
We do not have any foreign operations and thus we are not exposed to foreign currency fluctuation risks.
Item 8. Financial Statements and Supplementary Data.
See the index at Part IV, Item 15. Exhibits and Financial Statement Schedules
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
None.